<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="chapter-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">978-3-319-72962-6</journal-id>
<journal-id journal-id-type="doi">10.1007/978-3-319-72962-6</journal-id>
<journal-id journal-id-type="nlm-ta">Middle Ear Diseases</journal-id>
<journal-title-group>
<journal-title>Middle Ear Diseases</journal-title>
<journal-subtitle>Advances in Diagnosis and Management</journal-subtitle>
</journal-title-group>
<isbn publication-format="print">978-3-319-72961-9</isbn>
<isbn publication-format="electronic">978-3-319-72962-6</isbn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmc">7122426</article-id>
<article-id pub-id-type="publisher-id">2</article-id>
<article-id pub-id-type="doi">10.1007/978-3-319-72962-6_2</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Acute Otitis Media and Acute Coalescent Mastoiditis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Mansour</surname>
<given-names>Salah</given-names>
</name>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Magnan</surname>
<given-names>Jacques</given-names>
</name>
<xref ref-type="aff" rid="Aff6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nicolas</surname>
<given-names>Karen</given-names>
</name>
<xref ref-type="aff" rid="Aff7">7</xref>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Haidar</surname>
<given-names>Hassan</given-names>
</name>
<xref ref-type="aff" rid="Aff9">9</xref>
</contrib>
<aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="GRID">grid.411324.1</institution-id><institution-id institution-id-type="ISNI">0000 0001 2324 3572</institution-id><institution>Lebanese University, Department of Otolaryngology, </institution><institution>HNS Amoudi Center Boulevard Mazraa, </institution></institution-wrap>Beirut, Lebanon </aff>
<aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2176 4817</institution-id><institution-id institution-id-type="GRID">grid.5399.6</institution-id><institution>Aix-Marseille University, </institution></institution-wrap>Marseille, France </aff>
<aff id="Aff7"><label>7</label>Department of Radiology, Middle East Institute of Health, Bsalim, Lebanon </aff>
<aff id="Aff8"><label>8</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2324 3572</institution-id><institution-id institution-id-type="GRID">grid.411324.1</institution-id><institution>Lebanese University, </institution></institution-wrap>Beirut, Lebanon </aff>
<aff id="Aff9"><label>9</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0571 546X</institution-id><institution-id institution-id-type="GRID">grid.413548.f</institution-id><institution>Department of Otolaryngology, </institution><institution>Hamad Medical Corporation, Weill Cornell Medical College, </institution></institution-wrap>Doha, Qatar </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>28</day>
<month>07</month>
<year>2018</year>
</pub-date>
<fpage>85</fpage>
<lpage>113</lpage>
<permissions>
<copyright-statement>© Springer International Publishing AG, part of Springer Nature 2018</copyright-statement>
<license>
<license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Acute otitis media is a frequent manifestation of otitis media, mainly during the early childhood. The multifactorial pathogenesis and risk factors are exposed along with its most microbiological agents. The clinical manifestations and their differential diagnoses are presented. General concepts and different actual guidelines of the treatment are described, also the efficient preventive measures are proposed.</p>
<p id="Par2">The second main issue of this chapter is to deal with the complications of acute otitis media, especially the acute coalescent mastoiditis, that is the most common suppurative complication of AOM. The pathogenesis of coalescent acute mastoiditis, its epidemiology, risk factors and the microbiological agents are presented. The clinical features and differential diagnosis are described, as the specific imaging findings. Complications of acute coalescent mastoiditis are typically the subperiosteal abscess, due to the cortical bony necrosis of the mastoid and its septa, or the intracranial spread of the infection (meningitis, intracranial abscesses and venous sinus thrombosis).</p>
<p id="Par3">The general concept of management is exposed, with emphasis on the antimicrobial treatment and the different surgical options.</p>
</abstract>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© Springer International Publishing AG, part of Springer Nature 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Introduction</title>
<p id="Par4"> Otitis media (OM) comprises a wide spectrum of diseases that include acute otitis media (AOM), recurrent acute otitis media (rAOM), otitis media with effusion (OME), chronic otitis media with effusion (COME) and chronic suppurative otitis media (CSOM) [<xref ref-type="bibr" rid="CR1">1</xref>–<xref ref-type="bibr" rid="CR3">3</xref>].</p>
<p id="Par5">AOM is an acute inflammation and infection of the middle ear caused by bacteria and/or viruses. In general, it is a childhood disease that manifests as a rapid onset of fever and otalgia [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]; if the child has ≥3 episodes of AOM in the preceding 6 months, or ≥4 episodes in the preceding 12 months, he should be considered to have rAOM [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. Patients who have more than six episodes in the first 6 years of life are called otitis “prone ” [<xref ref-type="bibr" rid="CR7">7</xref>]. The presence of fluid in the middle ear with absence of acute signs and symptoms of infection and inflammation is defined as OME, and if the fluid persisted more than 3 months, it is considered as COME [<xref ref-type="bibr" rid="CR1">1</xref>]. CSOM is defined as an ear discharge with tympanic membrane (TM) perforation for more than 3 months [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
<p id="Par6">This chapter will scope on AOM and its complications, mainly acute and coalescent mastoiditis.</p>
</sec>
<sec id="Sec2">
<title>Epidemiology</title>
<p id="Par7"><bold>AOM</bold> is the second most common reason for a family physician’s visit and the most common reason for prescribing antimicrobial drugs. It accounts for 10–15% of all childhood medical visits.</p>
<p id="Par8">AOM has an incidence rate of 10.8/100 people per year [<xref ref-type="bibr" rid="CR8">8</xref>]. <italic>70% of children manifest at least one episode of AOM even in developed countries.</italic> Males have a higher incidence of AOM [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR9">9</xref>].</p>
<p id="Par9">AOM has a peak incidence at the age of 6–11 months [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]; 59% of children will have one episode of AOM and 30% will have two episodes or more by the age of 2 [<xref ref-type="bibr" rid="CR1">1</xref>]. <bold>rAOM</bold> resolve spontaneously when the child gets older, often at 3–4 years of age. AOM incidence rate drops rapidly after the age of 5 years.</p>
</sec>
<sec id="Sec3">
<title>Pathogenesis</title>
<p id="Par10">AOM has multiple risk factors (host factors, environmental, microbiological and genetic factors) that interact with each other and make the patient more susceptible to become affected by AOM [<xref ref-type="bibr" rid="CR10">10</xref>–<xref ref-type="bibr" rid="CR12">12</xref>].</p>
<p id="Par11">AOM is related to upper respiratory infections (URTI): More than 90% of AOM episodes develop after <bold><italic>URTI</italic></bold> [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]; one of three children will develop AOM after URTI [<xref ref-type="bibr" rid="CR12">12</xref>]. URTI causes nasopharyngitis which affects Eustachian tube function, and induces a negative pressure in the middle ear with secondary suction of the nasopharyngeal secretions inside the middle ear. This explains why aspirates of AOM can show bacteria like <italic>Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis</italic> [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR9">9</xref>], which are commensal to the nasopharynx [<xref ref-type="bibr" rid="CR13">13</xref>]. This mechanism is exaggerated by bottle-feeding, pacifier use, and other sucking behaviors. The initial course of the disease is thought to be of viral origin followed by superimposed bacterial infections [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. Many viruses have been implicated as causative agents which are found in 90% of AOM cases, such as the rhinovirus, coronavirus, enterovirus, respiratory syncytial virus (RSV), parainfluenza type 1, 2 or 3, influenza A or B, and adenovirus [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Among all of these, RSV is believed to have the most frequent association with AOM [<xref ref-type="bibr" rid="CR12">12</xref>]. These viruses are thought to increase the adherence of the bacteria to the epithelium so enhancing bacterial colonization [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>], however, there is a rising evidence that viruses alone can cause AOM without bacterial superinfection in 10–15% of cases, a point that should be kept in mind while treating AOM with antibiotics [<xref ref-type="bibr" rid="CR12">12</xref>, <xref ref-type="bibr" rid="CR14">14</xref>].</p>
<p id="Par12"><bold>Genetics</bold> play an important role in the susceptibility of an individual to AOM [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]: When comparing genetic to environmental risk factors, genetic predisposition with a specific genotype was found to be a stronger risk factor than the socioeconomic status. Positive family history of otitis media is a strong risk factor for developing AOM and other forms of otitis media.</p>
<p id="Par13">Native American Maori or Australian Aborigine populations have more prevalence of AOM as compared to the white population [<xref ref-type="bibr" rid="CR1">1</xref>]. One cohort study showed that heritability is found in 38.5% in rAOM [<xref ref-type="bibr" rid="CR11">11</xref>]. Some investigators have linked this susceptibility to inherited poor ET function [<xref ref-type="bibr" rid="CR2">2</xref>]. Other investigators found that specific polymorphisms of some cytokines have been correlated to the susceptibility of an individual to AOM and to the severity of the disease as well [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. IL-1s, IL-6 and TNFα have been found in nasopharyngeal secretions during URTI and increased levels of IL-1s are linked to the transition to AOM [<xref ref-type="bibr" rid="CR12">12</xref>]. TNFα-308 polymorphisms are associated with AOM that follows URTI. In addition, some rAOM patients were found to have TNFα-308 and IL-6-174 polymorphisms [<xref ref-type="bibr" rid="CR12">12</xref>]. Genes for Fcg-receptor IIa (FcgRIIa), IL-10, CD14, toll-like receptor 4 (TLR4), surfactant, and interferon gamma (IFNg) are believed to be responsible for an AOM risk [<xref ref-type="bibr" rid="CR11">11</xref>].</p>
<p id="Par14">The importance of environmental factors must not be underestimated in the pathogenesis of AOM; is one of otitis media major risk factors [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR8">8</xref>–<xref ref-type="bibr" rid="CR10">10</xref>]. Passive smoking causes mucosal inflammation, goblet cells hyperplasia and an increase in the production of mucus, all together impairs mucosal muco-ciliary clearance and increases bacterial colonization by enhancing the bacterial binding to respiratory epithelium [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. Children of mothers who smoked during pregnancy and stopped after delivery still have a higher incidence of AOM [<xref ref-type="bibr" rid="CR10">10</xref>].</p>
<p id="Par15">Some studies found a role of gastroesophageal reflux disease (GERD) [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR15">15</xref>]; is found in 62.9% of patient with rAOM. In fact, pepsin/pepsinogen can be found in the middle ear in 85.3% of otitis media patients that could be explained by the reflux; however a cause and effect relationship could not be established [<xref ref-type="bibr" rid="CR15">15</xref>].</p>
<p id="Par16">There are <bold>other</bold> risk factors that are related to AOM, like prematurity [<xref ref-type="bibr" rid="CR9">9</xref>], young age [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR8">8</xref>], day care attendance [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>], increased number of siblings, dummy use [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR9">9</xref>], autumn and winter seasons [<xref ref-type="bibr" rid="CR1">1</xref>], craniofacial anomalies [<xref ref-type="bibr" rid="CR8">8</xref>], asthma [<xref ref-type="bibr" rid="CR3">3</xref>] and atopy [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR8">8</xref>] (Fig. <xref ref-type="fig" rid="Fig1">2.1</xref>).</p>
<p id="Par17">An epidemiological survey from Denmark [<xref ref-type="bibr" rid="CR16">16</xref>] stated that the following factors were predictive of early AOM and rAOM: male gender, prematurity, parity (number of pregnancies the mother has had), maternal age, maternal self-estimated health, maternal intake of penicillin during pregnancy, and termination of breastfeeding before the child was 6 months old (Fig. <xref ref-type="fig" rid="Fig1">2.1</xref>).<fig id="Fig1"><label>Fig. 2.1</label><caption><p>Interactive predisposing factors of acute otitis media</p></caption><graphic id="MO1" xlink:href="431517_1_En_2_Fig1_HTML"></graphic></fig></p>
</sec>
<sec id="Sec4">
<title>Microbiology</title>
<p id="Par18">AOM is usually a complication of an acute viral upper respiratory infection. The most common bacterial pathogens associated with the diagnosis of AOM are: <italic>Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis</italic> [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>].</p>
<p id="Par19"> is the most common, found in 35–45% [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Patients infected with this microorganism tend to have more severe disease [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. The serotypes responsible have been changed after the introduction of pneumococcal 7-valent conjugate vaccine (PCV-7) [<xref ref-type="bibr" rid="CR3">3</xref>].</p>
<p id="Par20"> has become more common after PCV-7 vaccine [<xref ref-type="bibr" rid="CR3">3</xref>]. It is related to bilateral disease, recurrent cases, and conjunctivitis with the so called “otitis-conjunctivitis syndrome” [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR17">17</xref>].</p>
<p id="Par21"> is found in 10–20% of cases [<xref ref-type="bibr" rid="CR17">17</xref>], 100% are beta lactamase producers [<xref ref-type="bibr" rid="CR17">17</xref>].</p>
<p id="Par22">All of the above pathogens have the ability to form biofilms [<xref ref-type="bibr" rid="CR13">13</xref>], which are thought to be responsible for the resistance to antimicrobial therapy [<xref ref-type="bibr" rid="CR13">13</xref>].</p>
<p id="Par23"><bold><italic>Group A Streptococcus, Group B Streptococcus, Staphylococcus aureus and gram-negative bacilli</italic></bold> are other bacteria that can be encountered in approximately 15% of cases [<xref ref-type="bibr" rid="CR3">3</xref>]. A first episode of bacterial infection with invasive strains (like invasive strains of <italic>Streptococcus pneumoniae</italic>) can lead to mucosal changes which make the ear more susceptible to acquire the disease by less virulent strains [<xref ref-type="bibr" rid="CR19">19</xref>].</p>
<p id="Par24"><italic>Approximately 5% of ears have multiple pathogens. In approximately 20–30% of ears with clinical AOM</italic> [<xref ref-type="bibr" rid="CR20">20</xref>], <italic>no bacterial pathogen was identified by tympanocentesis.</italic></p>
<p id="Par25">Respiratory viruses including RSV, rhinovirus, adenovirus, influenza virus, parainfluenza virus, and CMV are isolated from the cultures of approximately 20% of middle ear samples, half of them have bacterial/viral co-infections [<xref ref-type="bibr" rid="CR20">20</xref>].</p>
<p id="Par26">In cases of simultaneous infection with pathogenic viruses and bacteria, antibiotic response appears to be inferior to that of children that have only a bacterial infection, and microbiologic failure can occur despite clear in vitro sensitivity to the used antibiotic. Consequently, a second course of antibiotics can effectively clear the bacteria after the immune system has cleared up the viral infection.</p>
</sec>
<sec id="Sec5">
<title>Clinical Manifestations</title>
<sec id="Sec6">
<title>Symptomatology</title>
<p id="Par27">AOM has typically a short history of onset; it is commonly associated with fever, otalgia, ear pulling, irritability, lethargy, anorexia, and vomiting.</p>
<p id="Par28">Earache <italic>is one of the most common and distressing symptoms of AOM.</italic></p>
<p id="Par29"><italic>Ear</italic> pulling is not specific as only 10% of ear pullers will have AOM.</p>
<p id="Par30">These symptoms alone lack sensitivity and specificity; the diagnosis of AOM must rely on otoscopy findings.</p>
<p id="Par31">Immunosuppressed patients, particularly those undergoing chemotherapy, may not manifest the typical acute inflammatory symptoms whereas systemic sepsis and middle ear effusion might be the only indicators of AOM.</p>
</sec>
<sec id="Sec7">
<title>Examination</title>
<p id="Par2019">Performed under ideal conditions, otomicroscopy with adequate visualization of the eardrum (cleaning the ear canal is most often required) allows proper diagnosis of AOM (Fig. <xref ref-type="fig" rid="Fig2">2.2</xref>). Non-cooperative children usually need to be restrained. Diagnosis may be difficult in very young children but it is important to accurately do so. A first episode of AOM before 6 months of age is likely to lead to recurrence of AOM, and subsequently, significant periods of OME with diminished hearing and delayed speech.<fig id="Fig2"><label>Fig. 2.2</label><caption><p>Left ear acute otitis media with bulging of the hyperemic tympanic membrane and yellowish effusion in the middle ear cavity</p></caption><graphic id="MO2" xlink:href="431517_1_En_2_Fig2_HTML"></graphic></fig></p>
<p id="Par32">The common otoscopic findings of AOM are:<list list-type="bullet"><list-item><p id="Par33"><bold>Hyperemic</bold> and hypervascularized tympanic membrane. Early AOM may be diagnosed by inflammation which is seen along the handle of malleus and in the superior pole of the tympanic membrane.</p></list-item><list-item><p id="Par34"><bold>Bulging</bold> tympanic membrane is the only specific sign for AOM. In the absence of a bulging ear drum but with clinical suspicion of AOM, pneumatic otoscopy is necessary to differentiate AOM from myringitis.</p></list-item><list-item><p id="Par1000"><bold>Purulent effusion</bold> behind a bulging tympanic membrane.</p></list-item><list-item><p id="Par35">When the process advances, a <bold>perforation</bold> of the tympanic membrane may occur, which allows spontaneous drainage of pus from middle ear and the patient would generally experience rapid relief of the pain and fever. Nowadays, it is not unusual that the otologist sees the patient at this stage. During otoscopic examination, a yellowish pulsatile discharge is seen oozing through pinpoint perforation.</p></list-item><list-item><p id="Par36"><bold>The discharge</bold> is initially purulent, though it may be thin and watery or bloody; pulsation of the otorrhea is common. Otorrhea from an acute perforation normally lasts 1–2 days before spontaneous healing occurs. Otorrhea may persist if the perforation is accompanied by mucosal swelling or polypoid changes.</p></list-item></list></p>
</sec>
</sec>
<sec id="Sec8">
<title>Diagnosis</title>
<p id="Par37">The diagnosis of AOM requires the presence of inflammation and pus in the middle ear, and acute onset of symptoms and sign of ear infection, i.e., earache, fever, irritability, poor feeding or vomiting, often associated with cough and rhinitis.</p>
<p id="Par38">Diagnosis of acute otitis media (AOM) requires<list list-type="order"><list-item><p id="Par39">Symptoms of fever, otalgia, or irritability in young children</p></list-item><list-item><p id="Par40">Bulging of the tympanic membrane</p></list-item><list-item><p id="Par41">Erythema and hypervascularisation</p></list-item></list></p>
<p id="Par42"> in AOM is very painful and must be avoided.</p>
<p id="Par43"> and are helpful to differentiate AOM from <italic>acute bullous myringitis</italic> and other differential diagnosis (Fig. <xref ref-type="fig" rid="Fig3">2.3</xref>).</p>
<p id="Par999"><bold><italic>Tympanometry</italic></bold> is helpful but must still be used in conjunction with compatible history.</p>
<p id="Par44"><bold><italic>Tympanocentesis</italic></bold>: Tympanocentesis is considered as the gold standard therapy in AOM; especially after failure of second course of antibiotics, the aspirate provides material for the culture to direct antibiotherapy [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR7">7</xref>].</p>
<p id="Par45"><bold><italic>Laboratory studies</italic></bold>: Not needed for the diagnosis. However one study by Pichichero and Almudevar indicated that the presence of AOM caused by non-typeable <italic>H. influenzae</italic>, as well as the disease’s cure, can be determined from serum levels of S100A12 protein and interleukin-10 (IL-10) [<xref ref-type="bibr" rid="CR21">21</xref>].</p>
<p id="Par46"><bold><italic>Imaging studies</italic></bold>: Radiologic studies are generally unnecessary in uncomplicated AOM. Role of CT-Scan or MRI in the diagnosis of complications will be presented in a dedicated chapter (see Chap. 10.1007/978-3-319-72962-6_9).</p>
</sec>
<sec id="Sec9">
<title>Differential Diagnosis of AOM</title>
<p id="Par47">
<list list-type="bullet"><list-item><p id="Par998"><bold><italic>Myringitis</italic></bold> - inflammation of the tympanic membrane. This is usually associated with viral infections of the upper respiratory tract.</p></list-item><list-item><p id="Par48"> , (rare) - caused by <italic>Mycoplasma pneumonia</italic>, and causes severe localized otalgia without systemic symptoms and without middle ear effusion. The bullae or blebs may contain serous or hemorrhagic fluid and pain is relieved by puncturing the bleb without opening the eardrum (Fig. <xref ref-type="fig" rid="Fig3">2.3</xref>).<fig id="Fig3"><label>Fig. 2.3</label><caption><p>Right ear otoscopy in a child presented with ear pain and fever showing bullous myringitis</p></caption><graphic id="MO3" xlink:href="431517_1_En_2_Fig3_HTML"></graphic></fig></p></list-item><list-item><p id="Par49">Otitis externa, rare in children, usually occurs after swimming and is associated with severe pain and tragal tenderness. The child is usually afebrile with good general condition.</p></list-item><list-item><p id="Par50">Dental pain</p></list-item><list-item><p id="Par51">Acute viral pharyngitis </p></list-item></list>
</p>
</sec>
<sec id="Sec10">
<title>Management of AOM</title>
<sec id="Sec11">
<title>General Concepts</title>
<p id="Par52">
<list list-type="order"><list-item><p id="Par53">
<italic>Routine use of antibiotics, especially in children 2 years and older, is not indicated because of the high rate of spontaneous resolution. Watchful waiting for 48 to 72 hours before initiating antibiotic therapy if symptoms are manageable with analgesics.Acute otitis media (AOM)managementconcepts</italic>
</p></list-item><list-item><p id="Par54">
<italic>The goals of antibiotic treatment of AOM are to:</italic>
<list list-type="bullet"><list-item><label></label><p id="Par789">• <italic>Produce fast clinical cure</italic></p></list-item><list-item><label></label><p id="Par788">• <italic>Prevent complications</italic></p></list-item><list-item><label></label><p id="Par786">• <italic>Eradicate bacteria from middle ear and thus reduce recurrence rate</italic></p></list-item></list>
</p></list-item><list-item><p id="Par55">
<italic>The most important factor is not to prescribe antibiotics for inappropriate diagnosis of AOM. Inappropriate use of antibiotics have caused adverse effects and increased antibiotic resistance.</italic>
</p></list-item><list-item><p id="Par2749">
S. pneumonia has the lowest spontaneous resolution rate and is associated with more serious complications, it is essential to ensure optimal coverage for this organism.
</p></list-item><list-item><p id="Par61"><italic>Observation alone is not suitable for high-risk or vulnerable populations such as indigenous children in remote settings or those with cleft palate, Down syndrome or immunodeficiency syndromes</italic> [<xref ref-type="bibr" rid="CR2">2</xref>]</p></list-item><list-item><p id="Par62">
<italic>Children younger than 6 months of age with AOM must be treated with antibiotics without the initial observational waiting time.</italic>
</p></list-item><list-item><p id="Par63">
<italic>Oral antibiotic treatment of a first AOM episode occurring during infancy does not affect the number of AOM recurrences.</italic>
</p></list-item><list-item><p id="Par7890">Persistent otitis media infections can arise from the failure to completely eradicate the original bacterial infection, the presence of biofilms, or intracellular bacterial infection of the middle ear mucosal cells, particularly mucus-secreting cells [<xref ref-type="bibr" rid="CR22">22</xref>].</p></list-item></list>
</p>
</sec>
<sec id="Sec12">
<title>Guidelines</title>
<p id="Par64">
<list list-type="bullet"><list-item><p id="Par65">Every nation has its own guidelines of therapy recommendations, there is no universal guidelines. In general, guidelines are more applied by the young generation of physicians than by the older ones.</p></list-item><list-item><p id="Par66">Most guidelines use the same diagnostic criteria, and propose <italic>watchful waiting</italic> in mild-moderate scenarios</p></list-item><list-item><p id="Par67">
<italic>The routine prescription of antibiotics for AOM ranges from 31% in the Netherlands to 98% in the USA and Australia.</italic>
</p></list-item><list-item><p id="Par68">
<italic>Current American Academy of Pediatrics Guidelines for the treatment of AOM recommend:</italic>
<list list-type="bullet"><list-item><p id="Par69"><italic>that antibiotics should be used in children aged over 6 months when unilateral or bilateral AOM is severe (moderate to severe otalgia, otalgia lasting at least 48 h, temperature 39 °C) </italic>[<xref ref-type="bibr" rid="CR23">23</xref>].</p></list-item><list-item><p id="Par70">
<italic>Antibiotics should also be prescribed if AOM is not severe but bilateral in a child aged 6–23 months.</italic>
</p></list-item><list-item><p id="Par71">
<italic>In the case of non-severe unilateral AOM in a child aged 6–23 months, or non-severe unilateral/bilateral AOM in a child aged 24 months or older, antibiotics may be prescribed or observation offered; if observation is chosen, a mechanism should be in place to give antibiotics if symptoms do not improve in 48–72 h.</italic>
</p></list-item></list>
</p></list-item><list-item><p id="Par72"><bold><italic>For rAOM</italic></bold><italic>, insertion of ventilation tubes should be considered if rAOM is associated with a persistent middle ear effusion between AOM attacks</italic> [<xref ref-type="bibr" rid="CR24">24</xref>]</p></list-item><list-item><p id="Par73">
<italic>No prophylactic antibiotics for</italic>
<italic>rAOM</italic>
</p></list-item></list>
</p>
</sec>
<sec id="Sec13">
<title>Choice of Antibiotics</title>
<p id="Par74">
<list list-type="alpha-lower"><list-item><p id="Par75">
<bold><italic>Amoxicillin</italic></bold>
<italic>is the first-line agent for the treatment of acute otitis media in children</italic> [<xref ref-type="bibr" rid="CR5">5</xref>–<xref ref-type="bibr" rid="CR7">7</xref>]<italic>; as most S. pneumoniae and H. influenzae are still susceptible</italic> [<xref ref-type="bibr" rid="CR9">9</xref>]<italic>. If severe signs and symptoms persisted more than 2–3 days of amoxicillin use, then antibiotics should be changed to amoxicillin-clavulanate, or second generation or third generation cephalosporin</italic> [<xref ref-type="bibr" rid="CR5">5</xref>].</p></list-item><list-item><p id="Par76"><italic>If there is a recent history of amoxicillin use in the last 30 days, in recurrent cases or if the patient has conjunctivitis, then Beta lactamase coverage should be added [</italic><xref ref-type="bibr" rid="CR5">5</xref><italic>, </italic><xref ref-type="bibr" rid="CR7">7</xref><italic>]. </italic><italic>Cefdinir, cefuroxime and ceftriaxone should be considered in case of penicillin allergy</italic> [<xref ref-type="bibr" rid="CR5">5</xref>]<italic>, macrolides can be used in allergic cases as well</italic> [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR9">9</xref>].</p></list-item></list>
</p>
</sec>
<sec id="Sec14">
<title>The Duration of Antibiotherapy</title>
<p id="Par77">The duration of antibiotherapy <italic>is for 10 days for children below 2 years and 5–7 days for older children</italic> [<xref ref-type="bibr" rid="CR5">5</xref>–<xref ref-type="bibr" rid="CR7">7</xref>]<italic>. Children who present with perforation of the tympanic membrane should receive 10 days of antibiotic therapy.</italic></p>
<p id="Par78">
<bold><italic>Antibiotherapy of 10 Days Duration</italic></bold>
<list list-type="order"><list-item><p id="Par79">
<bold><italic>&lt; 24 months old</italic></bold>
</p></list-item><list-item><p id="Par80">
<bold><italic>Perforated eardrum</italic></bold>
</p></list-item><list-item><p id="Par81">
<bold><italic>Recurrent AOM</italic></bold>
</p></list-item><list-item><p id="Par82">
<bold><italic>Failure of first line agents</italic></bold>
</p></list-item></list>
</p>
<p id="Par83">
<italic>Clinicians should reevaluate a child whose symptoms have worsened or that did not respond to the initial antibiotic treatment within 48–72 h and change the treatment.</italic>
</p>
<p id="Par84">It is not indicated to give antihistamine, decongestants or corticosteroids [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR6">6</xref>].</p>
</sec>
<sec id="Sec15">
<title>Tympanocentesis</title>
<p id="Par86">Few days after the start of the therapy, when the medical treatment is ineffective and the purulent effusion is under pressure, tympanocentesis is the solution because it permits an efficient drainage and immediate relief of symptoms and allows identification of the causative bacteria and its sensitivity. Also it is found that tube insertion reduces the recurrence rates of AOM [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR9">9</xref>], and improves the quality of life of children in terms of hearing and speech [<xref ref-type="bibr" rid="CR5">5</xref>]. Actually one of the main factors behind the rAOM is the lack of good control of the first episode of AOM when the ear is left with an important residual middle ear effusion.</p>
<p id="Par87">Tympanocentesis should be performed in the following AOM patients [<xref ref-type="bibr" rid="CR25">25</xref>]:<list list-type="bullet"><list-item><p id="Par88">Patients in whom adequate antimicrobial treatment has failed to control the infection</p></list-item><list-item><p id="Par89">Patients who have a complication that requires a culture for adequate therapy</p></list-item><list-item><p id="Par90">Neonates younger than 6 weeks (more likely to have an unusual invasive pathogen)</p></list-item><list-item><p id="Par91">Patients who are immunosuppressed or immunocompromised</p></list-item></list></p>
</sec>
<sec id="Sec16">
<title>Anti-GERD</title>
<p id="Par92">No sufficient data is present about using anti-reflux in rAOM [<xref ref-type="bibr" rid="CR15">15</xref>] but some studies found that controlling GERD by anti-reflux medication can decrease rAOM and tympanostomy tube insertion rates.</p>
</sec>
<sec id="Sec17">
<title>Follow up</title>
<p id="Par93">Normally the symptoms of AOM should resolve within 72 hours of initiating antibiotic treatment. However, middle ear effusion may persist for up to 1 month in 50% and up to 3 months in 25% of patients despite bacteriological cure. Therefore, persistence of middle ear fluid after full course of antibiotic therapy for AOM is not an indication for continued antimicrobial therapy. Follow up should be done after 4–8 weeks for uncomplicated cases of AOM to look for persistent middle ear effusion [<xref ref-type="bibr" rid="CR6">6</xref>] (See Chap. 10.1007/978-3-319-72962-6_3). In general, AOM is a symptomatic disease and screening is not indicated [<xref ref-type="bibr" rid="CR8">8</xref>]. </p>
</sec>
</sec>
<sec id="Sec18">
<title>Prevention of Recurrent AOM</title>
<p id="Par94">Recurrent otitis media (rAOM) is defined as 3 or more episodes of AOM over the preceding 6 months, or 4 or more episodes in the last year. Under these circumstance, prevention of further attacks is desirable. Modification of risk factors, when possible, are of benefit. Breast feeding has a protective effect at least for the first 6 months and preferentially to be continued for the first year [<xref ref-type="bibr" rid="CR5">5</xref>]. Elimination of smoking from the environment and avoidance of pacifiers have been shown to help reduce the recurrence of AOM. Vaccinations are other preventive measures [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. PCV7 has been shown to decrease AOM rates and tympanostomy tube placement for recurrent diseases [<xref ref-type="bibr" rid="CR26">26</xref>] and is more effective if given during infancy [<xref ref-type="bibr" rid="CR6">6</xref>]. It can prevent the early episodes of the disease and prevent the mucosal changes, that make the ear more susceptible to infection by other <italic>S. pneumoniae</italic> serotypes, that are not covered by PCV [<xref ref-type="bibr" rid="CR19">19</xref>]. Some studies found that Live Attenuated Influenza Vaccine (LAIV) has decreased the incidence of AOM by 12.4%, if given between 6 and 71 months of age [<xref ref-type="bibr" rid="CR7">7</xref>], but others found influenza vaccine is not effective in preventing AOM [<xref ref-type="bibr" rid="CR6">6</xref>]. The American Academy of Pediatrics recommends administration of pneumococcal conjugate vaccine and influenza vaccine for all children [<xref ref-type="bibr" rid="CR5">5</xref>].</p>
<p id="Par95">Despite promising results, there is still a real concern about the long-term benefit from vaccination. A recent study has highlighted concerns regarding the increasing incidence of AOM-related complications. Following the introduction of vaccinations, AOM-related complications, including mastoiditis and other intracranial complications, diminished considerably, however, they returned to pre-vaccination levels after a few years [<xref ref-type="bibr" rid="CR27">27</xref>]. Antibiotic prophylaxis has only minimal effects on recurrent otitis media, decreasing recurrence by approximately one episode per year. Antibiotic prophylaxis is no longer recommended in the management of rAOM. </p>
<p id="Par9027">As the child grows older, the incidence of recurrence declines.</p>
</sec>
<sec id="Sec19">
<title>Acute Otitis Media in Adult</title>
<p id="Par96">
<bold>AOM in adult is:</bold>
</p>
<p id="Par97">
<italic>Much less</italic>
<italic>common</italic>
<italic>than in children: the incidence in adults is widely quoted as 0.25% per year.</italic>
<list list-type="bullet"><list-item><p id="Par98">Mostly bacteria and mainly <italic>Haemophilus Influenzae</italic> is the dominating germ; <italic>S. pneumoniae</italic> is less involved since vaccination</p></list-item><list-item><p id="Par99">Otalgia is a more common presenting symptom and may occur without fever or hearing loss and may be the only presenting feature.</p></list-item><list-item><p id="Par100">Complications are rare</p></list-item></list>
</p>
<p id="Par101">
<italic>Immediate antibiotic prescription to an adult with AOM:</italic>
<list list-type="bullet"><list-item><p id="Par102">To patients who are systemically unwell but do not require admission.</p></list-item><list-item><p id="Par103">To those at high risk of complications because of significant heart, lung, kidney, diabetes, liver or neuromuscular disease, or to those who are immunocompromised.</p></list-item></list>
</p>
</sec>
<sec id="Sec20">
<title>Complications of Acute Otitis Media</title>
<p id="Par104">Tympanic membrane perforation occurs in 7% of the cases and tends to heal in 98% of cases in the first 1–2 weeks [<xref ref-type="bibr" rid="CR7">7</xref>]. Other complications and sequelae of AOM are important causes of preventable hearing loss, particularly in developing countries. <bold><italic>Meningitis</italic></bold> (pneumococcal origin of AOM is the most important pathogen linked to meningitis [<xref ref-type="bibr" rid="CR7">7</xref>]), facial <bold><italic>palsy and coalescent mastoiditis</italic></bold>. Also systemic complications could occur such as bacteremia, septic arthritis, or bacterial endocarditis.</p>
<sec id="Sec21">
<title>Facial Paralysis</title>
<p id="Par105">Incidence: <italic>Nowadays</italic>
<italic>, facial paralysis is a very uncommon complication of AOM with an estimated incidence of 0.005%; it was not so rare in the pre-antibiotic era</italic> [<xref ref-type="bibr" rid="CR28">28</xref>].</p>
<p id="Par106"><bold>Mechanism of facial paralysis:</bold> It is thought that facial paralysis in AOM is caused by spread of infection under pressure from the middle ear cavity into the facial nerve sheath with resultant intrafallopian inflammatory edema and consequent ischemia and neuropraxia. Presumably this occurs either through [<xref ref-type="bibr" rid="CR1">1</xref>] preexistent bony dehiscences [<xref ref-type="bibr" rid="CR2">2</xref>], physiologic canaliculi between the middle ear and the Fallopian canal, or [<xref ref-type="bibr" rid="CR3">3</xref>] vascular connections between the Fallopian canal and the mastoid air cells.</p>
<p id="Par107"><bold>Site of involvement:</bold> the exact site of the inflammatory involvement causing facial palsy in AOM is difficult to determine, but through the topographic tests it was observed that the site of involvement is infrageniculate in 90% of cases and suprageniculate in 10% [<xref ref-type="bibr" rid="CR29">29</xref>].</p>
<p id="Par108"><bold>Treatment:</bold> it is a consensus among most otologists that the conservative approach for facial palsy in AOM is the most appropriate one: it consists of <italic>antibiotherapy and</italic>
<italic>myringotomy with tube placement; steroids may be added.</italic> In certain cases when the facial recovery is delayed and the patient keeps a grade VI paralysis after 3 weeks of treatment, imaging is indicated to rule out associated pathologies.</p>
<p id="Par110">Unlike in CSOM, facial palsy in AOM presents, in most cases, an excellent prognosis with the adequate treatment.</p>
</sec>
</sec>
<sec id="Sec22">
<title>Acute Coalescent Mastoiditis in Children</title>
<p id="Par111"><italic>Acute</italic>
<italic>coalescent mastoiditis</italic>
<italic>is the most common suppurative complication of</italic>
<italic>AOM in young children</italic>.</p>
<p id="Par112">In many cases, this may be the presenting complaint of children with AOM. Early diagnosis and adequate treatment of this condition are essential to avoid fatal complications. In the era of antibiotics, coalescent mastoiditis has an incidence of &lt;1% in patients with AOM [<xref ref-type="bibr" rid="CR30">30</xref>]. The incidence and the clinical picture of mastoiditis have changed greatly with the advent of antibiotics when reliance on antibiotics alone leads to less vigilance in diagnostic and therapeutic interventions; “this has led to a generation of ENT specialists and pediatricians trained in an atmosphere of complacency in the treatment of AOM; recently, a delay is noted in the recognition of mastoiditis and its related intracranial complications in children and in the initiation of the appropriate therapy” [<xref ref-type="bibr" rid="CR31">31</xref>].</p>
<p id="Par113">Despite the use of advanced imaging modalities, antibiotics, and microsurgical procedures, the resulting mortality of intracranial otogenic complications in acute coalescent mastoiditis remains of approximately 10% [<xref ref-type="bibr" rid="CR32">32</xref>].</p>
<sec id="Sec23">
<title>Definitions</title>
<p id="Par114">Acute mastoiditis is subdivided according to the pathologic stage:<list list-type="bullet"><list-item><p id="Par115"> (also called incipient mastoiditis) is defined by the presence of purulent material only in the mastoid cavity.</p></list-item><list-item><p id="Par116"><bold>Acute coalescent mastoiditis</bold> (also called “ acute mastoid osteitis”) <bold><italic>is defined by the acute form of destruction of the thin bony septae between mastoid air cells</italic></bold>. It may be followed by the formation of abscess cavities and the dissipation of pus into adjacent areas.</p></list-item><list-item><p id="Par117"> (also called subacute mastoiditis) refers to a low-grade, subacute, but persistent infection in the middle ear and mastoid with destruction of the bony septae between air cells. It occurs in patients with persistent middle ear effusion or recurrent episodes of AOM without sufficient antimicrobial therapy.</p></list-item></list></p>
</sec>
<sec id="Sec24">
<title>Pathogenesis</title>
<p id="Par118">The clinical course of AOM is often short and self limited because of the host’s immune system defense, the infection-resistant nature of the mucosal linings, and the susceptibility of the major organisms to oral antibiotics.</p>
<p id="Par119">Approximately 1–5% of untreated or inadequately treated patients with AOM may experience complications. Prior to these complications, alarming signs and symptoms may appear: severe earache and/or headache; vertigo; chills and fever; and meningeal symptoms or signs [<xref ref-type="bibr" rid="CR33">33</xref>].</p>
<p id="Par120">Acute coalescent mastoiditis is a rare complication of severe AOM. During an episode of severe AOM, the mucosa in the epitympanum becomes hyperplastic, it blocks the aditus ad antrum leading to entrapment of purulent material within the mastoid air cells. As pus and granulations accumulate under pressure, mastoid air cells bony septation become subjected to pressure and osteitic necrosis; small air cells coalesce into larger ones by bony septation necrosis with a resultant <italic>coalescence of mastoid air cells</italic> called “acute coalescent mastoiditis” (Fig. <xref ref-type="fig" rid="Fig4">2.4</xref>).<fig id="Fig4"><label>Fig. 2.4</label><caption><p>Pathogenesis of coalescent mastoiditis</p></caption><graphic id="MO4" xlink:href="431517_1_En_2_Fig4_HTML"></graphic></fig></p>
<p id="Par121">Essentially, coalescent mastoiditis is an empyema of the temporal bone. Pus may leave the area of coalescence by direct extension, thrombophlebitis, or through preformed bony pathways. If the outer cortical bone is violated a postauricular, subperiosteal abscess is formed, causing an ear protrusion downward and outward. However, if the inner cortical table is violated, an intracranial complication can occur: sigmoid sinus thrombosis, meningitis, epidural or subdural abscess, or brain abscess.</p>
<p id="Par123"> Subperiosteal abscess is seen in nearly 50% of patients diagnosed with coalescent mastoiditis [<xref ref-type="bibr" rid="CR34">34</xref>–<xref ref-type="bibr" rid="CR37">37</xref>]. If not recognized at its early stage, the coalescent mastoiditis could be the cause of fatal intracranial complications. The incidence of intracranial complications has been reported between 6.8% and 23% when acute mastoiditis is diagnosed [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>] (see Chap. 10.1007/978-3-319-72962-6_9).</p>
</sec>
<sec id="Sec25">
<title>Risk Factors</title>
<p id="Par124">As with most infectious processes, host and microbial factors have to be considered when evaluating acute mastoiditis (Fig. <xref ref-type="fig" rid="Fig5">2.5</xref>).<fig id="Fig5"><label>Fig. 2.5</label><caption><p>Risk factors of acute coalescent mastoiditis</p></caption><graphic id="MO5" xlink:href="431517_1_En_2_Fig5_HTML"></graphic></fig></p>
<sec id="Sec26">
<title>Host Factors</title>
<p id="Par125"><bold>Age &lt; 2 years</bold>: Most children presenting with acute coalescent mastoiditis are younger than 2 years of age and have little history of otitis media. At this age, the immune system is relatively immature, particularly with regard to its ability to respond to challenges from polysaccharide antigens.</p>
<p id="Par126"><bold>Incomplete mastoid pneumatization</bold>: Mastoid antrum is the only mastoid air cell present at birth. Mastoid pneumatization starts shortly after birth, but it is not active during the first two years of life. After the age of 2 years, mastoid pneumatization becomes very active and is almost complete at the age of 10 years. The antrum and the mastoid air cells are lined with respiratory epithelium that becomes oedematous due to inflammation and infection. Non-pneumatized mastoid is more prone to coalescent mastoiditis because the narrow aditus ad antrum can be easily blocked by inflammatory epitympanic mucosa during an episode of severe AOM.</p>
<p id="Par127">Other host factors, such , have shown an increased likelihood of developing middle ear infections and more than two-fold greater predisposition for coalescent mastoiditis [<xref ref-type="bibr" rid="CR40">40</xref>].</p>
</sec>
<sec id="Sec27">
<title>Microbial Factors</title>
<p id="Par128"> The most common etiologic agent causing mastoiditis is <italic>Streptococcus pneumoniae</italic>, followed by <italic>Haemophilus influenzae</italic> and group A <italic>Streptococcus pyogenes</italic> (GAS). Each of these bacteria has invasive forms and is recovered most often from children presenting with acute mastoiditis.</p>
<p id="Par129">Reported pathogens in mastoiditis include the following [<xref ref-type="bibr" rid="CR41">41</xref>–<xref ref-type="bibr" rid="CR60">60</xref>]<list list-type="bullet"><list-item><p id="Par130"><italic>Streptococcus pneumoniae</italic>—Most frequently isolated pathogen in acute mastoiditis, prevalence is approximately 25%</p></list-item><list-item><p id="Par131">
<italic>Group A beta-hemolytic streptococci</italic>
</p></list-item><list-item><p id="Par132">
<italic>Staphylococcus aureus</italic>
</p></list-item><list-item><p id="Par133">
<italic>Streptococcus pyogenes</italic>
</p></list-item><list-item><p id="Par134">
<italic>Haemophilus</italic>
<italic>influenzae</italic>
</p></list-item></list></p>
<p id="Par856">Several case series show that 33–81% of patients diagnosed with acute coalescent mastoiditis had been treated with appropriate first-line agents for AOM prior to development of mastoiditis, suggesting that antibiotics administered for AOM treatment do not eliminate the risk of developing this complication [<xref ref-type="bibr" rid="CR61">61</xref>].</p>
</sec>
</sec>
<sec id="Sec28">
<title>Epidemiology (Figs. <xref ref-type="fig" rid="Fig6">2.6</xref> and <xref ref-type="fig" rid="Fig7">2.7</xref>)</title>
<p id="Par135"> Today, the estimated incidence of coalescent mastoiditis is less than 0.01% of AOM [<xref ref-type="bibr" rid="CR55">55</xref>]. <fig id="Fig6"><label>Fig. 2.6</label><caption><p>Epidemiology of acute coalescent mastoiditis</p></caption><graphic id="MO6" xlink:href="431517_1_En_2_Fig6_HTML"></graphic></fig><fig id="Fig7"><label>Fig. 2.7</label><caption><p>The evolution of incidence of acute coalescent mastoiditis over time</p></caption><graphic id="MO7" xlink:href="431517_1_En_2_Fig7_HTML"></graphic></fig></p>
<p id="Par136">Acute mastoiditis is a disease of the very young. Most patients present younger than the age of 2 years, with a median age of 12 months. However, it can occur in persons of any age. Some fear that untreated otitis media increases the risk of acute mastoiditis and is the cause of higher incidences in developing countries and very young children [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>].</p>
<p id="Par137">In the pre-antibiotic era, up to 20% of cases of AOM were complicated by acute mastoiditis and were frequently associated with more severe intracranial complications [<xref ref-type="bibr" rid="CR64">64</xref>].</p>
<p id="Par138">The advent of sulfonamides in the 1930s and 1940s decreased hospitalizations for AOM by 50% and mastoidectomies by 80% [<xref ref-type="bibr" rid="CR65">65</xref>]. This reduction was amplified with the introduction of penicillin and other early antibiotic regimens directed toward common pathogens of the middle ear [<xref ref-type="bibr" rid="CR66">66</xref>]. The reported incidences decreased from 0.4% in 1959 [<xref ref-type="bibr" rid="CR67">67</xref>] to 0.004% in the 1980s [<xref ref-type="bibr" rid="CR68">68</xref>].</p>
<p id="Par139">Since 1989, however, several investigators have documented an epidemiologic resurgence of acute mastoiditis in children [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR67">67</xref>–<xref ref-type="bibr" rid="CR71">71</xref>]. Some studies have incriminated the common practice of administering broad-spectrum antibiotics in increasing the prevalence of resistant bacteria that can spread the infection into the mastoid bone [<xref ref-type="bibr" rid="CR72">72</xref>–<xref ref-type="bibr" rid="CR76">76</xref>].</p>
<p id="Par140">The incidence of acute mastoiditis in children &lt;2 years of age exhibited a dynamic pattern from 1999 to 2008: a significant decline early after introduction of PCV-7 was followed by an increase in subsequent years to pre-PCV-7 levels.</p>
<p id="Par141">A retrospective review of pediatric patients in Colorado found that the annual incidence of acute coalescent mastoiditis in children under age 2 years dropped from 11.0 per 100,000 population in 2001, a year after PCV-7 was introduced, to 4.5 per 100,000 population in 2003. By 2008, however, the incidence had again raised to 12 per 100,000 population [<xref ref-type="bibr" rid="CR77">77</xref>].</p>
<p id="Par142">Non-PCV-7 pneumococcal serotypes and increased pneumococcal antibiotic resistance may be responsible for this increase in incidence in comparison to pre-PCV-7 rates.</p>
<p id="Par144">
<italic>Although becoming less common, coalescent mastoiditis remains even nowadays a subject of first interest and concern for pediatricians and otolaryngologists</italic>
<italic>.</italic>
</p>
</sec>
<sec id="Sec29">
<title>Clinical Features</title>
<p id="Par145">Approximately 40% of children with acute mastoiditis had a positive history of previous AOM, and 50% of patients having coalescent mastoiditis had received antibiotics before presentation. However, the absence of AOM (current or recent) does not exclude the diagnosis of coalescent mastoiditis because it may take place very rapidly during the onset of an AOM episode.</p>
<p id="Par146">The diagnosis of acute mastoiditis is usually made clinically in children with characteristic findings. The most frequent diagnostic criteria include (Figs. <xref ref-type="fig" rid="Fig8">2.8</xref> and <xref ref-type="fig" rid="Fig9">2.9</xref>):<list list-type="order"><list-item><p id="Par147">Irritability and lethargy</p></list-item><list-item><p id="Par148">Fever</p></list-item><list-item><p id="Par149">Otalgia</p></list-item><list-item><p id="Par150">Postauricular erythema, tenderness, swelling, fluctuance, or mass</p></list-item><list-item><p id="Par151">Protrusion of the auricle</p></list-item><list-item><p id="Par152">Oedema and sagging of the posterosuperior wall of the external auditory canal</p></list-item><list-item><p id="Par153">Nipplelike protrusion of the central tympanic membrane, usually oozing pus</p></list-item></list><fig id="Fig8"><label>Fig. 2.8</label><caption><p>Main clinical features of acute coalescent mastoiditis</p></caption><graphic id="MO8" xlink:href="431517_1_En_2_Fig8_HTML"></graphic></fig><fig id="Fig9"><label>Fig. 2.9</label><caption><p>Signs and symptoms of acute coalescent mastoiditis in order of frequency: Lethargy/malaise (96%); Abnormal tympanic membrane (82%); Postauricular erythema, postauricular tenderness, and/or protrusion of the pinna (80%); Fever (76%); Narrowing of the external auditory canal (71%); Ear pain (67%); Otorrhea (50%)</p></caption><graphic id="MO9" xlink:href="431517_1_En_2_Fig9_HTML"></graphic></fig></p>
<p id="Par154"> is a nonspecific sign but it is sensitive and may be predictive of complications or the need for surgical intervention. High-spiking “picket-fence” fever may be indicative of sigmoid sinus thrombophlebitis.</p>
<p id="Par155"><bold>Examination of the tympanic membrane: </bold> Tympanic membrane findings consistent with AOM (e.g., bulging, marked erythema or acute perforation with purulent otorrhea in the absence of otitis externa) are often present.</p>
<p id="Par156">A normal-appearing tympanic membrane usually (but not invariably) excludes mastoiditis.</p>
<p id="Par157"><bold>Laboratory Features</bold>: The peripheral white blood cell count in children with acute coalescent mastoiditis is usually elevated, often with a left shift. The erythrocyte sedimentation rate and C-reactive protein are also elevated.</p>
<p id="Par158">Immunologic evaluation may be warranted in children with recurrent episodes of AOM leading to mastoiditis.</p>
</sec>
<sec id="Sec30">
<title>CT-Imaging</title>
<p id="Par159">The CT Imaging plays a determinant role in confirming the diagnosis and in orienting plans for management. CT allows differentiation between a mere condensation of the mastoid system in common acute purulent otitis media and disruption of the intercellular bone septa that is indicative for coalescent mastoiditis. Also CT-Scan may confirm the diagnosis in children without characteristic clinical findings.</p>
<p id="Par160">
<bold>CT findings in children with acute coalescent mastoiditis include the following:</bold>
<list list-type="order"><list-item><p id="Par161"><italic>Fluid and/or mucosal thickening in the middle ear and mastoid condensation images</italic>: this is a nonspecific finding that occurs early in the course; it is often seen in children with AOM with mastoiditis and may even be observed as an incidental finding in asymptomatic children.</p></list-item><list-item><p id="Par162"><italic>Loss of definition of the bony septae that define the mastoid air cells</italic>: this finding is diagnostic of coalescent mastoiditis (Fig. <xref ref-type="fig" rid="Fig10">2.10</xref>).</p></list-item><list-item><p id="Par163"><italic>Destruction or irregularity of the mastoid cortex</italic> (Fig. <xref ref-type="fig" rid="Fig11">2.11</xref>).</p></list-item><list-item><p id="Par164"><italic>Periosteal thickening, disruption of the periosteum, subperiosteal abscess</italic> (Figs. <xref ref-type="fig" rid="Fig10">2.10</xref> and <xref ref-type="fig" rid="Fig11">2.11</xref>).</p></list-item></list>
<fig id="Fig10"><label>Fig. 2.10</label><caption><p>Axial non injected CT-image of a 2 y-o boy with acute otitis media on both sides. Mastoid cells are opacified on the right side (single arrow), the bony septa are preserved: non specific sign of mastoiditis. On the left side, the bony septa of the mastoid are resorbed (double arrow): sign of coalescent mastoiditis. Associated large retroauricular soft tissue swelling (between the white arrows) with protrusion of the auricle (empty arrow), but no lysis of the mastoid cortex. Note the diffuse condensation of the ethmoidal (E) and sphenoidal (S) sinusses</p></caption><graphic id="MO10" xlink:href="431517_1_En_2_Fig10_HTML"></graphic></fig>
<fig id="Fig11"><label>Fig. 2.11</label><caption><p>Axial non injected CT-image of another 1½ year child, with acute otitis media and retroauricular swelling. (<bold>a</bold>) The mastoid is not well developed, atticoantral and mastoid cell condensations. (<bold>b</bold>) destruction of the mastoid cortex (between the two arrows) and a voluminous extratemporal soft tissue thickening (*): subperiosteal abscess</p></caption><graphic id="MO11" xlink:href="431517_1_En_2_Fig11_HTML"></graphic></fig>
</p>
<p id="Par165">
<bold>In case of suspected complications, CT has preferentially to be done with contrast injection or should be followed by MRI, dependent on age and compliance of the patient.</bold>
</p>
</sec>
<sec id="Sec31">
<title>Differential Diagnosis</title>
<p id="Par166">The differential diagnosis of acute coalescent mastoiditis includes other causes of postauricular inflammation or swelling:<list list-type="bullet"><list-item><p id="Par167"> :This is a common mimicker of mastoiditis. Severe pain over the tragus and pinna differentiates this entity from mastoiditis.</p></list-item><list-item><p id="Par168"><bold>Perichondritis of the auricle</bold>: Characterized by swelling and erythema of the pinna and may spread to the periosteum of the postauricular area. In contrast to acute mastoiditis, the postauricular crease is preserved, and the tympanic membrane appears normal.</p></list-item><list-item><p id="Par169"> : Benign and malignant tumors of the mastoid bone (e.g., aneurysmal bone cyst, acute lymphocytic leukemia, Langerhans cell histiocytosis) may have clinical features similar to mastoiditis.</p></list-item></list></p>
</sec>
<sec id="Sec32">
<title>Complications</title>
<p id="Par170">Complications of coalescent mastoiditis are related to the spread of infection from the middle ear or mastoid to contiguous structures. In some cases, the complication is the presenting complaint.</p>
<p id="Par171">In most case series, the rate of complications is approximately 10–20% (range 7–60%) [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>, <xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR79">79</xref>]. In a multicenter study, <italic>S. pyogenes</italic> was associated with the highest rate of complications at presentation (50%) and <italic>S. aureus</italic> with the highest rate of complications during hospitalization (31%) [<xref ref-type="bibr" rid="CR42">42</xref>].</p>
<sec id="Sec33">
<title>Extracranial Complications of Acute Coalescent Mastoiditis Include (See also Chap. 10.1007/978-3-319-72962-6_9)</title>
<sec id="Sec34">
<title>Subperiosteal Abscess—(Fig. <xref ref-type="fig" rid="Fig12">2.12</xref>)</title>
<p id="Par172">Signs of subperiosteal abscess include erythema, fluctuance, and a tender mass overlying the mastoid bone. Subperiosteal abscess occurs in about 50% of cases of acute mastoiditis [<xref ref-type="bibr" rid="CR79">79</xref>].<fig id="Fig12"><label>Fig. 2.12</label><caption><p>Coalescent mastoditis with subperiosteal abscess (<bold>a</bold>) schematic drawing (<bold>b</bold>) T1 weighted MRI image after i.v. injection of gadolinium showing the coalescent mastoiditis (M) with exteriorisation of the purulent material in the subperiosteal space (SPA) through a large cortical defect. An intracerebral abscess (ICA) is another concomitant complication in this case</p></caption><graphic id="MO12" xlink:href="431517_1_En_2_Fig12_HTML"></graphic></fig></p>
</sec>
<sec id="Sec35">
<title>Facial Nerve Palsy</title>
<p id="Par173"> Facial nerve palsycan result from infectious neuritis or inflammatory compression of the facial nerve as it traverses the temporal bone.</p>
</sec>
<sec id="Sec36">
<title>Labyrinthitis</title>
<p id="Par174">Clinical features of labyrinthitis include tinnitus, hearing loss, nausea, vomiting, dizziness, vertigo, and nystagmus. Labyrinthtitis is caused by spread of bacteria from the middle ear to the labyrinthine space through the round window membrane. More often the involvement of the labyrinth is a reaction to bacterial exotoxins rather than bacterial invasion. This so-called otogenic labyrinthitis is unilateral in contrast to meningogenic labyrinthitis which is usually bilateral. MRI is the study of choice and shows that the endo- and perilymphatic spaces are filled with purulent material (Fig. <xref ref-type="fig" rid="Fig13">2.13a</xref>). The inner ear enhances on the T1-weighted images performed after gadolinium injection (Fig. <xref ref-type="fig" rid="Fig13">2.13b</xref>).<fig id="Fig13"><label>Fig. 2.13</label><caption><p>Axial IRM images of a coalescent mastoiditis complicated by labyrinthitis (<bold>a</bold>) T2 weighted axial image showing purulent material in the mastoid as being slightly hyperintense (*). The endolymphatic/perilymphatic spaces of the cochlea (short arrow) and the semicircular canals (long arrow) are hypointens, as the content of the IAC (white empty arrowhead) in comparison to the normal left side with hyperintense fluid in the cochlea (short dashed arrow), the semicircular canals (long dashed arrow) and the IAC (dashed arrowhead). (<bold>b</bold>) on T1 weighted image post Gd and fatsat, the purulent material in the mastoid does not show any enhancement (*), but the whole right labyrinth shows an important contrast uptake, also the ICA, in comparison to the normal left side (same annotations for the different anatomic structures as in (<bold>a</bold>)</p></caption><graphic id="MO13" xlink:href="431517_1_En_2_Fig13_HTML"></graphic></fig></p>
</sec>
<sec id="Sec37">
<title>Petrous apicitis</title>
<p id="Par175">Infection in the mastoid may spread to other parts of the skull, resulting in osteomyelitis. Osteomyelitis of the petrous apex may be associated with facial nerve palsy or Gradenigo syndrome (i.e., otorrhea, retro-orbital pain, ipsilateral abducens [sixth cranial nerve] palsy, and possibly other cranial nerve deficits) .</p>
</sec>
<sec id="Sec38">
<title>Bezold abscess</title>
<p id="Par176">A Bezold abscess is a neck abscess located in the sheath of the sternocleidomastoid muscle. Clinical features of Bezold abscess include swelling and tenderness below the mastoid process and under the sternocleidomastoid muscle.</p>
</sec>
</sec>
<sec id="Sec39">
<title>Intracranial Complications of Acute Coalescent Mastoiditis</title>
<p id="Par177"> Intracranial complications occurs in about 6% to 23% of cases with coalescent mastoiditis [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR79">79</xref>]. Altered mental status, neurologic deficits including cranial nerve palsy, high fever, neck stiffness, seizures, and severe headache should be concerning for intracranial disease.</p>
<sec id="Sec40">
<title>Meningitis</title>
</sec>
<sec id="Sec41">
<title>Temporal Lobe or Cerebellar Abscess</title>
<p id="Par179">Increasing temporoparietal headache, near the affected ear, is often the only indication of otogenic brain abscess formation [<xref ref-type="bibr" rid="CR33">33</xref>] (See Figs. 10.1007/978-3-319-72962-6_9#Fig17–10.1007/978-3-319-72962-6_9#Fig20, Sect. 10.1007/978-3-319-72962-6_9#Sec24).</p>
</sec>
<sec id="Sec42">
<title>Epidural or Subdural Abscess</title>
<p id="Par180">Although rarely seen, among all intracranial complications of middle ear disease, epidural abscess formation is the most common [<xref ref-type="bibr" rid="CR80">80</xref>] (See Fig. 10.1007/978-3-319-72962-6_9#Fig19, Sect. 10.1007/978-3-319-72962-6_9#Sec24).</p>
</sec>
<sec id="Sec43">
<title>Venous Sinus Thrombosis</title>
<p id="Par181">Sinus thrombosis is the least frequent one [<xref ref-type="bibr" rid="CR81">81</xref>]. Sigmoid sinus thrombosis has become increasingly uncommon, whereas in the pre-antibiotic era this complication was mortal in over 90% of the cases [<xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR82">82</xref>].</p>
<p id="Par182">Patients may present with otorrhea, otalgia, neck pain, fever, and chills [<xref ref-type="bibr" rid="CR83">83</xref>]. But often presenting signs and symptoms are subtle or nonspecific and not in proportion to the magnitude of the problem, leading to a common delay in diagnosis [<xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR85">85</xref>]. Consequently, a high index of suspicion is actually required to make the diagnosis [<xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR82">82</xref>].</p>
<p id="Par183">Imaging studies should be performed in all coalescent mastoiditis patients with pain or vertigo that is not rapidly resolving after appropriate antibiotic treatment [<xref ref-type="bibr" rid="CR82">82</xref>] (See Figs. 10.1007/978-3-319-72962-6_9#Fig14 and 10.1007/978-3-319-72962-6_9#Fig15, Sect. 10.1007/978-3-319-72962-6_9#Sec24). The therapeutic strategy is a point of debate, and ranges from internal jugular vein ligation, anticoagulation therapy, to the administration of less conventional antibiotic therapy [<xref ref-type="bibr" rid="CR86">86</xref>].</p>
</sec>
</sec>
</sec>
<sec id="Sec44">
<title>Management</title>
<sec id="Sec45">
<title>General Concept</title>
<p id="Par184">The treatment of acute coalescent mastoiditis depends upon the stage and presence or absence of complications.<list list-type="bullet"><list-item><p id="Par185">
<bold><italic>Antimicrobial therapy and drainage of the middle ear and mastoid are the cornerstones of therapy for coalescent mastoiditis.</italic></bold>
</p></list-item></list></p>
<p id="Par186">
<list list-type="bullet"><list-item><p id="Par187"><bold><italic>The rates of</italic></bold> in treatment of acute coalescent mastoiditis vary greatly in the range between 9 and 88%, as is reported in the literature [<xref ref-type="bibr" rid="CR62">62</xref>]</p></list-item><list-item><p id="Par188">
<bold><italic>alone</italic></bold> may fail to prevent the development of complications of acute coalescent mastoiditis. In a series of 223 patients, 8.5% developed complications during antimicrobial therapy [<xref ref-type="bibr" rid="CR42">42</xref>].</p></list-item><list-item><p>The use of single, high-dose intravenous (IV) steroids is warranted to decrease mucosal swelling and promote natural drainage through the aditus ad antrum into the middle ear.</p></list-item><list-item><p id="Par189">
<bold>may be warranted if one or more of the following are present</bold>
<list list-type="bullet"><list-item><p id="Par190">Postauricular fluctuant, mass, or swelling (suggesting subperiosteal abscess)</p></list-item><list-item><p id="Par191">Cervical fluctuance (i.e., Bezold abscess).</p></list-item><list-item><p id="Par192">Imaging studies with evidence of rim-enhancing fluid collection, mastoid air cell coalescence, cortical bone erosion, or intracranial involvement.</p></list-item><list-item><p id="Par193">High-spiking “picket-fence” fever (may indicate sigmoid sinus thrombophlebitis)</p></list-item><list-item><p id="Par194">Neurologic signs (e.g., facial weakness, meningeal signs, focal deficits, altered level of consciousness, seizures); consultation by a neurosurgeon is also indicated.</p></list-item></list>
</p></list-item></list>
</p>
</sec>
<sec id="Sec46">
<title>Management of Uncomplicated Coalescent Mastoiditis</title>
<p id="Par195">
<list list-type="bullet"><list-item><p id="Par196">
<bold><italic>Uncomplicated</italic></bold>
<bold><italic>acute coalescent mastoiditis is treated with intravenous (IV) antimicrobial therapy and myringotomy with placement of a tympanostomy tube</italic></bold>
</p></list-item></list>
</p>
<p id="Par197">Numerous patients with uncomplicated mastoiditis respond well to conservative treatment. Unfortunately, we are still not able to predict which patient will have a poor response or which will develop severe complications.<list list-type="bullet"><list-item><p id="Par198">
<bold><italic>Patients should be monitored daily for clinical response. If there is no clinical improvement in 48 h, mastoidectomy should be done</italic></bold>
<bold><italic>.</italic></bold>
</p></list-item></list></p>
</sec>
<sec id="Sec47">
<title>Management of Complicated Mastoiditis</title>
<p id="Par199">
<bold><italic>Acute coalescent</italic></bold>
<bold><italic>mastoiditis with extracranial or intracranial complications is usually treated with IV antibiotics, myringotomy with placement of a tympanostomy tube, and mastoidectomy.</italic></bold>
</p>
<p id="Par200">When a subperiosteal abscess is noted at presentation<italic>, some otologists favor postauricular aspiration as the initial procedure</italic> [<xref ref-type="bibr" rid="CR87">87</xref>].</p>
</sec>
<sec id="Sec48">
<title>Antimicrobial Therapy</title>
<p id="Par201">Because of the diversity of causative organisms in acute coalescent mastoiditis and the growing resistance of bacteria to the various antibiotics, all means to obtain a sample for culture and sensitivity prior to antibiotic treatment should be taken.</p>
<p id="Par202"> Empiric antimicrobial therapy for children with acute mastoiditis without a history of recurrent AOM or recent antibiotic administration should provide coverage for the most frequent bacterial pathogens: <italic>S. pneumoniae</italic> (including multiply resistant <italic>S. pneumoniae</italic>), <italic>S. pyogenes</italic>, and <italic>S. aureus</italic> (including methicillin-resistant <italic>S. aureus</italic>).</p>
<p id="Par203">In a child with either no previous history of AOM or a history of a remote episode (i.e., &gt;6 months before), empiric antimicrobial therapy with <ext-link ext-link-type="uri" xlink:href="https://www.uptodate.com/contents/vancomycin-pediatric-drug-information?source=see_link"><italic>vancomycin</italic></ext-link> alone (60 mg/kg per day divided every 6 h with a maximum dose of 4 gm/day) should be started until microbiologic results are available.</p>
<p id="Par204">For children with a history of recurrent AOM (most recent episode within 6 months) or recent antibiotic use, adequate coverage for gram-positive and gram-negative pathogens usually entails combination therapy. Antibiotics active against <italic>P. aeruginosa</italic> should be included in the empiric regimen.</p>
<p id="Par205">Upon diagnosis of the acute mastoiditis, initial antimicrobial is given intravenously. The patient can be switched to oral antibiotics when improved clinically and culture sensitivity days and oral antibiotics to complete a 4 weeks course.</p>
</sec>
<sec id="Sec49">
<title>Surgical Treatment</title>
<p id="Par207"><bold>Early drainage interrupts the pathologic process and prevents complications</bold> [<xref ref-type="bibr" rid="CR42">42</xref>].</p>
<sec id="Sec50">
<title>Myringotomy</title>
<p id="Par208"> Myringotomy permits drainage of the mastoid if the aditus ad antrum is not blocked. Tympanostomy tubes permit drainage over a longer duration. Postoperatively, antibiotic/steroid drops are used to keep the tube patent and to reduce middle ear swelling. Antibiotic/steroid drops are continued until the otorrhea ceases.</p>
</sec>
<sec id="Sec51">
<title>Mastoidectomy</title>
<p id="Par209"> Mastoidectomy is performed to remove the mastoid infection, open the aditus ad antrum, and provide external drainage. Indications for mastoidectomy may include:<list list-type="bullet"><list-item><p id="Par210">Computed tomography evidence of coalescent mastoiditis (regardless of other clinical features)</p></list-item><list-item><p id="Par211">Subperiosteal abscess</p></list-item><list-item><p id="Par212">Other suppurative complications of acute mastoiditis</p></list-item><list-item><p id="Par213">Progression or persistence of fever, ear pain, postauricular swelling, or drainage despite parenteral antimicrobial therapy and tympanocentesis/myringotomy</p></list-item></list></p>
</sec>
</sec>
<sec id="Sec52">
<title>Treatment Response</title>
<p id="Par214">The response to treatment of acute mastoiditis is monitored through serial examination of the postauricular region, the external auditory canal, and the tympanic membrane and through measurement of inflammatory markers (WBC count and CRP).</p>
<p id="Par215">In patients with acute mastoiditis, the above signs and symptoms should start to improve 48 hours after tympanocentesis/myringotomy and initiation of adequate antimicrobial therapy. Mastoidectomy is indicated in children who do not demonstrate adequate treatment response after 48 h. In this condition, imaging control of the temporal bone with intravenous contrast is indicated preoperatively.</p>
</sec>
<sec id="Sec53">
<title>Prevention</title>
<p id="Par216">Early and adequate treatment of AOM reduces the risk of developing mastoiditis. Early recognition of the coalescent mastoiditis and its prompt treatment will decrease the risk of developing complications of mastoiditis.</p>
</sec>
</sec>
<sec id="Sec54">
<title>Summary of Acute Coalescent Mastoiditis</title>
<p id="Par217">Acute coalescent mastoiditis is a complication of AOM in which purulent material accumulates within the mastoid cavity. As the pressure increases, the bony septae between the mastoid air cells may be destroyed (coalescent mastoiditis), abscess cavities may form, and the purulent material may progress into adjacent areas.</p>
<p id="Par218"> Characteristic featuresof coalescent mastoiditis include postauricular abnormalities (tenderness, erythema, swelling, fluctuance, mass and protrusion) of the auricle; most patients also have fever and ear pain.</p>
<p id="Par219">The diagnosis of acute coalescent mastoiditis is usually made clinically in children with characteristic examination findings. Imaging is necessary to confirm the diagnosis and evaluate suspected complications.</p>
<p id="Par220">Treatment requires empiric antimicrobial therapy and drainage of pus from the middle ear and mastoid cavity.</p>
<sec id="FPar9001" sec-type="conclusions">
<title>Conclusion</title>
<p id="Par221">AOM remains a common pathology for children even in developed countries. Its accurate diagnosis is simple and relies on adequate otoscopy. In nowadays practice, presumptive or confused diagnosis is inacceptable. The correct evaluation of the middle ear under perfect conditions during the presenting episode must be the rule. Antibiotics and paracentesis are the valuable means of treatment.</p>
<p id="Par222">Strict follow up when the child becomes asymptomatic is of the utmost importance in order to evaluate residual effusions, avoid recurrences, complications and sequelae. For these objectives, the positive collaboration between family physicians, pediatrics and otologists is a major disciplinary measure to implement for a better outcome.</p>
</sec>
</sec>
</sec>
</body>
<back>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhutta</surname>
<given-names>MF</given-names>
</name>
</person-group>
<article-title>Epidemiology and pathogenesis of otitis media: construction of a phenotype landscape</article-title>
<source/>Audiol Neurootol
          <year>2014</year>
<volume>19</volume>
<issue>3</issue>
<fpage>210</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="doi">10.1159/000358549</pub-id>
<pub-id pub-id-type="pmid">24819621</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Leach</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Acute and chronic otitis media</article-title>
<source/>Pediatr Clin N Am
          <year>2009</year>
<volume>56</volume>
<issue>6</issue>
<fpage>1383</fpage>
<lpage>1399</lpage>
<pub-id pub-id-type="doi">10.1016/j.pcl.2009.09.007</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cunningham</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Guardiani</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Brook</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Otitis media</article-title>
<source/>Future Microbiol
          <year>2012</year>
<volume>7</volume>
<issue>6</issue>
<fpage>733</fpage>
<lpage>753</lpage>
<pub-id pub-id-type="doi">10.2217/fmb.12.38</pub-id>
<pub-id pub-id-type="pmid">22702527</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pichichero</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>Acute otitis media: Part I. Improving diagnostic accuracy</article-title>
<source/>Am Fam Physician
          <year>2000</year>
<volume>61</volume>
<issue>7</issue>
<fpage>2051</fpage>
<lpage>2056</lpage>
<pub-id pub-id-type="pmid">10779248</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siddiq</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Grainger</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The diagnosis and management of acute otitis media: American Academy of Pediatrics Guidelines 2013</article-title>
<source/>Arch Dis Child Educ Pract Ed
          <year>2015</year>
<volume>100</volume>
<issue>4</issue>
<fpage>193</fpage>
<lpage>197</lpage>
<pub-id pub-id-type="doi">10.1136/archdischild-2013-305550</pub-id>
<pub-id pub-id-type="pmid">25395494</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wasson</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Yung</surname>
<given-names>MW</given-names>
</name>
</person-group>
<article-title>Evidence-based management of otitis media: a 5S model approach</article-title>
<source/>J Laryngol Otol
          <year>2015</year>
<volume>129</volume>
<issue>2</issue>
<fpage>112</fpage>
<lpage>119</lpage>
<pub-id pub-id-type="doi">10.1017/S0022215114003363</pub-id>
<pub-id pub-id-type="pmid">25627708</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thomas</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Berner</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Zahnert</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Dazert</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Acute otitis media – a structured approach</article-title>
<source/>Dtsch Arztebl Int
          <year>2014</year>
<volume>111</volume>
<issue>9</issue>
<fpage>151</fpage>
<lpage>159</lpage>
<pub-id pub-id-type="pmid">24661591</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schilder</surname>
<given-names>AG</given-names>
</name>
<name>
<surname>Chonmaitree</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Cripps</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Casselbrant</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Haggard</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Venekamp</surname>
<given-names>RP</given-names>
</name>
</person-group>
<article-title>Otitis media</article-title>
<source/>Nat Rev Dis Primers
          <year>2016</year>
<volume>2</volume>
<fpage>16063</fpage>
<pub-id pub-id-type="doi">10.1038/nrdp.2016.63</pub-id>
<pub-id pub-id-type="pmid">27604644</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atkinson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wallis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Coatesworth</surname>
<given-names>AP</given-names>
</name>
</person-group>
<article-title>Acute otitis media</article-title>
<source/>Postgrad Med
          <year>2015</year>
<volume>127</volume>
<issue>4</issue>
<fpage>386</fpage>
<lpage>390</lpage>
<pub-id pub-id-type="doi">10.1080/00325481.2015.1028872</pub-id>
<pub-id pub-id-type="pmid">25913598</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McCormick</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Grady</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Diego</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Matalon</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Revai</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Chonmaitree</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Acute otitis media severity: association with cytokine genepolymorphisms and other risk factors</article-title>
<source/>Int J Pediatr Otorhinolaryngol
          <year>2011</year>
<volume>75</volume>
<issue>5</issue>
<fpage>708</fpage>
<lpage>712</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijporl.2011.02.021</pub-id>
<pub-id pub-id-type="pmid">21440944</pub-id>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hafrén</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Kentala</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Järvinen</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Leinonen</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Onkamo</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Kere</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mattila</surname>
<given-names>PS</given-names>
</name>
</person-group>
<article-title>Genetic background and the risk of otitis media</article-title>
<source/>Int J Pediatr Otorhinolaryngol
          <year>2012</year>
<volume>76</volume>
<issue>1</issue>
<fpage>41</fpage>
<lpage>44</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijporl.2011.09.026</pub-id>
<pub-id pub-id-type="pmid">22018929</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nokso-Koivisto</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Marom</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chonmaitree</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Importance of viruses in acute otitis media</article-title>
<source/>Curr Opin Pediatr
          <year>2015</year>
<volume>27</volume>
<issue>1</issue>
<fpage>110</fpage>
<lpage>115</lpage>
<pub-id pub-id-type="doi">10.1097/MOP.0000000000000184</pub-id>
<pub-id pub-id-type="pmid">25514574</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vergison</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Microbiology of otitis media: a moving target</article-title>
<source/>Vaccine
          <year>2008</year>
<volume>26</volume>
<issue>Suppl 7</issue>
<fpage>G5</fpage>
<lpage>10</lpage>
<pub-id pub-id-type="doi">10.1016/j.vaccine.2008.11.006</pub-id>
<pub-id pub-id-type="pmid">19094935</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heikkinen</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Chonmaitree</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Importance of respiratory viruses in acute otitis media</article-title>
<source/>Clin Microbiol Rev
          <year>2003</year>
<volume>16</volume>
<issue>2</issue>
<fpage>230</fpage>
<lpage>241</lpage>
<pub-id pub-id-type="doi">10.1128/CMR.16.2.230-241.2003</pub-id>
<pub-id pub-id-type="pmid">12692096</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miura</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Mascaro</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>Association between otitis media and gastroesophageal reflux: a systematic review</article-title>
<source/>Otolaryngol Head Neck Surg
          <year>2012</year>
<volume>146</volume>
<issue>3</issue>
<fpage>345</fpage>
<lpage>352</lpage>
<pub-id pub-id-type="doi">10.1177/0194599811430809</pub-id>
<pub-id pub-id-type="pmid">22157391</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kørvel-Hanquist</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Koch</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Niclasen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Dammeye</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lous</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Olsen</surname>
<given-names>SF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Risk factors of early otitis media in the Danish National Birth Cohort</article-title>
<source/>PLoS One
          <year>2016</year>
<volume>11</volume>
<issue>11</issue>
<fpage>e0166465</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0166465</pub-id>
<pub-id pub-id-type="pmid">27851778</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gould</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Matz</surname>
<given-names>PS</given-names>
</name>
</person-group>
<article-title>Otitis media</article-title>
<source/>Pediatr Rev
          <year>2010</year>
<volume>31</volume>
<issue>3</issue>
<fpage>102</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1542/pir.31-3-102</pub-id>
<pub-id pub-id-type="pmid">20194902</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ngo</surname>
<given-names>CC</given-names>
</name>
<name>
<surname>Massa</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Thornton</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Cripps</surname>
<given-names>AW</given-names>
</name>
</person-group>
<article-title>Predominant bacteria detected from the middle ear fluid of children experiencing otitis media: a systematic review</article-title>
<source/>PLoS One
          <year>2016</year>
<volume>11</volume>
<issue>3</issue>
<fpage>e0150949</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0150949</pub-id>
<pub-id pub-id-type="pmid">26953891</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dagan</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Pelton</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bakaletz</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Prevention of early episodes of otitismedia by pneumococcal vaccines might reduce progression to complex disease</article-title>
<source/>Lancet Infect Dis
          <year>2016</year>
<volume>16</volume>
<issue>4</issue>
<fpage>480</fpage>
<lpage>492</lpage>
<pub-id pub-id-type="doi">10.1016/S1473-3099(15)00549-6</pub-id>
<pub-id pub-id-type="pmid">27036355</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shawabka</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Haidar</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Larem</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Aboul-Mahmood</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Alsaadi</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Acute otitis media- an update</article-title>
<source/>J Otolaryngol ENT Res
          <year>2017</year>
<volume>8</volume>
<issue>2</issue>
<fpage>00252</fpage>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pichichero</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Almudevar</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Serum cytokine biomarkers accurately predict presence of acute otitis media infection and recovery caused by Haemophilus influenzae</article-title>
<source/>Int J Pediatr Otorhinolaryngol
          <year>2016</year>
<volume>83</volume>
<fpage>200</fpage>
<lpage>204</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijporl.2016.02.007</pub-id>
<pub-id pub-id-type="pmid">26968077</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Massa</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Cripps</surname>
<given-names>AW</given-names>
</name>
<name>
<surname>Lehmann</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Otitis media: viruses, bacteria, biofilms and vaccines</article-title>
<source/>Med J Aust.
          <year>2009</year>
<volume>191</volume>
<issue>9 Suppl</issue>
<fpage>S44</fpage>
<pub-id pub-id-type="pmid">19883356</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<collab>American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media</collab>
</person-group>
<article-title>Diagnosis and management of acute otitis media</article-title>
<source/>Pediatrics
          <year>2004</year>
<volume>113</volume>
<issue>5</issue>
<fpage>1451</fpage>
<lpage>1465</lpage>
<pub-id pub-id-type="doi">10.1542/peds.113.5.1451</pub-id>
<pub-id pub-id-type="pmid">15121972</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rosenfeld</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Pynnonen</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Tunkel</surname>
<given-names>DE</given-names>
</name>
<name>
<surname>Hussey</surname>
<given-names>HM</given-names>
</name>
<name>
<surname>Fichera</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Grimes</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Hackell</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Haskell</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Haynes</surname>
<given-names>DS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Lafreniere</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>LeBlanc</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mackey</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Netterville</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Pipan</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Raol</surname>
<given-names>NP</given-names>
</name>
<name>
<surname>Schellhase</surname>
<given-names>KG</given-names>
</name>
</person-group>
<article-title>Clinical practice guideline: tympanostomy tubes in children</article-title>
<source/>Otolaryngol Head Neck Surg
          <year>2013</year>
<volume>149</volume>
<issue>1 Suppl</issue>
<fpage>S1</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="pmid">23818543</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<mixed-citation publication-type="other">Donaldson JD. Acute otitis media workup. In: Meyers AD, editor. Drugs &amp; diseases, Otolaryngology and facial plastic surgery; 2017.</mixed-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Levi</surname>
<given-names>Jessica R.</given-names>
</name>
<name>
<surname>Brody</surname>
<given-names>Robert M.</given-names>
</name>
<name>
<surname>McKee-Cole</surname>
<given-names>Katie</given-names>
</name>
<name>
<surname>Pribitkin</surname>
<given-names>Edmund</given-names>
</name>
<name>
<surname>O’Reilly</surname>
<given-names>Robert</given-names>
</name>
</person-group>
<article-title>Complementary and alternative medicine for pediatric otitis media</article-title>
<source/>International Journal of Pediatric Otorhinolaryngology
          <year>2013</year>
<volume>77</volume>
<issue>6</issue>
<fpage>926</fpage>
<lpage>931</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijporl.2013.03.009</pub-id>
<pub-id pub-id-type="pmid">23562352</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Daniel</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gautam</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Scrivener</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Meller</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Levin</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Curotta</surname>
<given-names>JJ</given-names>
</name>
</person-group>
<article-title>What effect has pneumococcal vaccination had on acute mastoiditis?</article-title>
<source/>Laryngol Otol
          <year>2013</year>
<volume>127</volume>
<issue>Suppl 1</issue>
<fpage>S30</fpage>
<lpage>S34</lpage>
<pub-id pub-id-type="doi">10.1017/S0022215112002654</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gaio</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Marioni</surname>
<given-names>G</given-names>
</name>
<name>
<surname>de Filippis</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tregnaghi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Caltran</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Staffieri</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Facial nerve paralysis secondary to acute otitis media in infants and children</article-title>
<source/>J Paediatr Child Health
          <year>2004</year>
<volume>40</volume>
<issue>8</issue>
<fpage>483</fpage>
<lpage>486</lpage>
<pub-id pub-id-type="doi">10.1111/j.1440-1754.2004.00436.x</pub-id>
<pub-id pub-id-type="pmid">15265194</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yonamine</surname>
<given-names>FK</given-names>
</name>
<name>
<surname>Tuma</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Silva</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Soares</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Testa</surname>
<given-names>JR</given-names>
</name>
</person-group>
<article-title>Facial paralysis associated with acute otitis media</article-title>
<source/>Braz J Otorhinolaryngol
          <year>2009</year>
<volume>75</volume>
<issue>2</issue>
<fpage>228</fpage>
<lpage>230</lpage>
<pub-id pub-id-type="doi">10.1016/S1808-8694(15)30782-5</pub-id>
<pub-id pub-id-type="pmid">19575108</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Piegel</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>Lustig</surname>
<given-names>LR</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Murr</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Schindler</surname>
<given-names>RA</given-names>
</name>
</person-group>
<article-title>Contemporary presentation and management of a spectrum of mastoid abscesses</article-title>
<source/>Laryngoscope
          <year>1998</year>
<volume>108</volume>
<issue>6</issue>
<fpage>822</fpage>
<lpage>828</lpage>
<pub-id pub-id-type="doi">10.1097/00005537-199806000-00009</pub-id>
<pub-id pub-id-type="pmid">9628496</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuczkowski</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Mikaszewski</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Intracranial complications of acute and chronic mastoiditis: report of two cases in children</article-title>
<source/>Int J Pediatr Otorhinolaryngol
          <year>2001</year>
<volume>60</volume>
<issue>3</issue>
<fpage>227</fpage>
<lpage>237</lpage>
<pub-id pub-id-type="doi">10.1016/S0165-5876(01)00524-9</pub-id>
<pub-id pub-id-type="pmid">11551614</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaftan</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Draf</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Intracranial otogenic complications: inspite of therapeutic progress still a serious problem</article-title>
<source/>Laryngorhinootologie
          <year>2000</year>
<volume>79</volume>
<issue>10</issue>
<fpage>609</fpage>
<lpage>615</lpage>
<pub-id pub-id-type="doi">10.1055/s-2000-7682</pub-id>
<pub-id pub-id-type="pmid">11089211</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dobben</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Raofi</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Mafee</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Kamel</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mercurio</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Otogenic intracranial inflammations: role of magnetic resonance imaging</article-title>
<source/>Top Magn Reson Imaging
          <year>2000</year>
<volume>11</volume>
<issue>2</issue>
<fpage>76</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="doi">10.1097/00002142-200004000-00003</pub-id>
<pub-id pub-id-type="pmid">10794197</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glynn</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Osman</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Colreavy</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Acute mastoiditis in children: Presentation and long term consequences</article-title>
<source/>J Laryngol Otol
          <year>2008</year>
<volume>122</volume>
<issue>3</issue>
<fpage>233</fpage>
<lpage>237</lpage>
<pub-id pub-id-type="doi">10.1017/S0022215107009929</pub-id>
<pub-id pub-id-type="pmid">17640433</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Psarommatis</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Giannakopoulos</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Theodorou</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Voudouris</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Carabinos</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Tsakanikos</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Mastoid subperiosteal abscess in children: drainage or mastoidectomy?</article-title>
<source/>The Journal of Laryngology &amp; Otology
          <year>2012</year>
<volume>126</volume>
<issue>12</issue>
<fpage>1204</fpage>
<lpage>1208</lpage>
<pub-id pub-id-type="doi">10.1017/S0022215112002332</pub-id>
<pub-id pub-id-type="pmid">23098060</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zevallos</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Vrabec</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>RA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Advanced pediatric mastoiditis with and without intracranial complications</article-title>
<source/>Laryngoscope
          <year>2009</year>
<volume>119</volume>
<issue>8</issue>
<fpage>1610</fpage>
<lpage>1615</lpage>
<pub-id pub-id-type="doi">10.1002/lary.20259</pub-id>
<pub-id pub-id-type="pmid">19504555</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<mixed-citation publication-type="other">
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/S0165-5876(00)00425-0">http://dx.doi.org/S0165-5876(00)00425-0</ext-link>
</mixed-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<mixed-citation publication-type="other">
<ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/S0165-5876(00)00283-4">http://dx.doi.org/S0165-5876(00)00283-4</ext-link>
</mixed-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luntz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Keren</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Nusem</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Acute mastoiditis—revisited</article-title>
<source/>Ear Nose Throat J
          <year>1994</year>
<volume>73</volume>
<issue>9</issue>
<fpage>648</fpage>
<lpage>654</lpage>
<pub-id pub-id-type="pmid">7988394</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adams</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Susi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Erdie-Lalena</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Gorman</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hisle-Gorman</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rajnik</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Elrod</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Nylund</surname>
<given-names>CM</given-names>
</name>
</person-group>
<article-title>Otitis media and related complications among children with autism spectrum disorders</article-title>
<source/>J Autism Dev Disord
          <year>2016</year>
<volume>46</volume>
<issue>5</issue>
<fpage>1636</fpage>
<lpage>1642</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-015-2689-x</pub-id>
<pub-id pub-id-type="pmid">26739355</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geva</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Oestreicher-Kedem</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Fishman</surname>
<given-names>G</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Conservative management of acute mastoiditis in children</article-title>
<source/>Int J Pediatr Otorhinolaryngol
          <year>2008</year>
<volume>72</volume>
<fpage>629</fpage>
<pub-id pub-id-type="doi">10.1016/j.ijporl.2008.01.013</pub-id>
<pub-id pub-id-type="pmid">18304656</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luntz</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Brodsky</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Nusem</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Acute mastoiditis – the antibiotic era: a multicenter study</article-title>
<source/>Int J Pediatr Otorhinolaryngol
          <year>2001</year>
<volume>57</volume>
<fpage>1</fpage>
<pub-id pub-id-type="doi">10.1016/S0165-5876(00)00425-0</pub-id>
<pub-id pub-id-type="pmid">11165635</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Katz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Leibovitz</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Acute mastoiditis in Southern Israel: a twelve year retrospective study (1990 through 2001)</article-title>
<source/>Pediatr Infect Dis J
          <year>2003</year>
<volume>22</volume>
<fpage>878</fpage>
<pub-id pub-id-type="doi">10.1097/01.inf.0000091292.24683.fc</pub-id>
<pub-id pub-id-type="pmid">14551488</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thorne</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Chewaproug</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Elden</surname>
<given-names>LM</given-names>
</name>
</person-group>
<article-title>Suppurative complications of acute otitis media: changes in frequency over time</article-title>
<source/>Arch Otolaryngol Head Neck Surg
          <year>2009</year>
<volume>135</volume>
<fpage>638</fpage>
<pub-id pub-id-type="doi">10.1001/archoto.2009.75</pub-id>
<pub-id pub-id-type="pmid">19620582</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Benito</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Gorricho</surname>
<given-names>BP</given-names>
</name>
</person-group>
<article-title>Acute mastoiditis: increase in the incidence and complications</article-title>
<source/>Int J Pediatr Otorhinolaryngol
          <year>2007</year>
<volume>71</volume>
<fpage>1007</fpage>
<pub-id pub-id-type="doi">10.1016/j.ijporl.2007.02.014</pub-id>
<pub-id pub-id-type="pmid">17493691</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bilavsky</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Yarden-Bilavsky</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Samra</surname>
<given-names>Z</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical, laboratory, and microbiological differences between children with simple or complicated mastoiditis</article-title>
<source/>Int J Pediatr Otorhinolaryngol
          <year>2009</year>
<volume>73</volume>
<fpage>1270</fpage>
<pub-id pub-id-type="doi">10.1016/j.ijporl.2009.05.019</pub-id>
<pub-id pub-id-type="pmid">19539381</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oestreicher-Kedem</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Raveh</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Kornreich</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Complications of mastoiditis in children at the onset of a new millennium</article-title>
<source/>Ann Otol Rhinol Laryngol
          <year>2005</year>
<volume>114</volume>
<fpage>147</fpage>
<pub-id pub-id-type="doi">10.1177/000348940511400212</pub-id>
<pub-id pub-id-type="pmid">15757196</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palma</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Fiumana</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Borgonzoni</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Acute mastoiditis in children: the “Ferrara” experience</article-title>
<source/>Int J Pediatr Otorhinolaryngol
          <year>2007</year>
<volume>71</volume>
<fpage>1663</fpage>
<pub-id pub-id-type="doi">10.1016/j.ijporl.2007.06.018</pub-id>
<pub-id pub-id-type="pmid">17681615</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ruiz Díaz</surname>
<given-names>AI</given-names>
</name>
<name>
<surname>del Castillo Martín</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Bilbao Garitagoitia</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Acute mastoiditis: an increasing entity</article-title>
<source/>An Esp Pediatr
          <year>2002</year>
<volume>57</volume>
<fpage>427</fpage>
<pub-id pub-id-type="doi">10.1016/S1695-4033(02)77960-5</pub-id>
<pub-id pub-id-type="pmid">12467546</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roddy</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Glazier</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Agrawal</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Pediatric mastoiditis in the pneumococcal conjugate vaccine era: symptom duration guides empiric antimicrobial therapy</article-title>
<source/>Pediatr Emerg Care
          <year>2007</year>
<volume>23</volume>
<fpage>779</fpage>
<pub-id pub-id-type="doi">10.1097/PEC.0b013e31815a0001</pub-id>
<pub-id pub-id-type="pmid">18007207</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ho</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rotenberg</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Berkowitz</surname>
<given-names>RG</given-names>
</name>
</person-group>
<article-title>The relationship between acute mastoiditis and antibiotic use for acute otitis media in children</article-title>
<source/>Arch Otolaryngol Head Neck Surg
          <year>2008</year>
<volume>134</volume>
<fpage>45</fpage>
<pub-id pub-id-type="doi">10.1001/archotol.134.1.45</pub-id>
<pub-id pub-id-type="pmid">18209135</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mustafa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Debry</surname>
<given-names>CH</given-names>
</name>
<name>
<surname>Wiorowski</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Treatment of acute mastoiditis: report of 31 cases over a ten year period</article-title>
<source/>Rev Laryngol Otol Rhinol (Bord)
          <year>2004</year>
<volume>125</volume>
<fpage>165</fpage>
<pub-id pub-id-type="pmid">15602860</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baljosevic</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Mircetic</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Subarevic</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Markovic</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Acute mastoiditis in infants</article-title>
<source/>Eur Arch Otorhinolaryngol
          <year>2006</year>
<volume>263</volume>
<fpage>906</fpage>
<pub-id pub-id-type="doi">10.1007/s00405-006-0085-z</pub-id>
<pub-id pub-id-type="pmid">16794812</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heslop</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ovesen</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Severe acute middle ear infections: microbiology and treatment</article-title>
<source/>Int J Pediatr Otorhinolaryngol
          <year>2006</year>
<volume>70</volume>
<fpage>1811</fpage>
<pub-id pub-id-type="doi">10.1016/j.ijporl.2006.06.009</pub-id>
<pub-id pub-id-type="pmid">16904758</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nussinovitch</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yoeli</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Elishkevitz</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Varsano</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Acute mastoiditis in children: epidemiologic, clinical, microbiologic, and therapeutic aspects over past years</article-title>
<source/>Clin Pediatr (Phila)
          <year>2004</year>
<volume>43</volume>
<fpage>261</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="doi">10.1177/000992280404300307</pub-id>
<pub-id pub-id-type="pmid">15094950</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ongkasuwan</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Valdez</surname>
<given-names>TA</given-names>
</name>
<name>
<surname>Hulten</surname>
<given-names>KG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates</article-title>
<source/>Pediatrics
          <year>2008</year>
<volume>122</volume>
<fpage>34</fpage>
<pub-id pub-id-type="doi">10.1542/peds.2007-2703</pub-id>
<pub-id pub-id-type="pmid">18595984</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stähelin-Massik</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Podvinec</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Jakscha</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mastoiditis in children: a prospective, observational study comparing clinical presentation, microbiology, computed tomography, surgical findings and histology</article-title>
<source/>Eur J Pediatr
          <year>2008</year>
<volume>167</volume>
<fpage>541</fpage>
<pub-id pub-id-type="doi">10.1007/s00431-007-0549-1</pub-id>
<pub-id pub-id-type="pmid">17668240</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Groth</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Enoksson</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hultcrantz</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Acute mastoiditis in children aged 0–16 years – a national study of 678 cases in Sweden comparing different age groups</article-title>
<source/>Int J Pediatr Otorhinolaryngol
          <year>2012</year>
<volume>76</volume>
<fpage>1494</fpage>
<pub-id pub-id-type="doi">10.1016/j.ijporl.2012.07.002</pub-id>
<pub-id pub-id-type="pmid">22832239</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anthonsen</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Høstmark</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Hansen</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Acute mastoiditis in children: a 10-year retrospective and validated multicenter study</article-title>
<source/>Pediatr Infect Dis J
          <year>2013</year>
<volume>32</volume>
<fpage>436</fpage>
<pub-id pub-id-type="doi">10.1097/INF.0b013e31828abd13</pub-id>
<pub-id pub-id-type="pmid">23380667</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghadersohi</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Young</surname>
<given-names>NM</given-names>
</name>
<name>
<surname>Smith-Bronstein</surname>
<given-names>V</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Management of acute complicated mastoiditis at an urban, tertiary care pediatric hospital</article-title>
<source/>Laryngoscope
          <year>2017</year>
<volume>127</volume>
<issue>10</issue>
<fpage>2321</fpage>
<lpage>2327</lpage>
<pub-id pub-id-type="doi">10.1002/lary.26365</pub-id>
<pub-id pub-id-type="pmid">27796038</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lieberthal</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Carroll</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Chonmaitree</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>The diagnosis and management of acute otitis media</article-title>
<source/>Pediatrics
          <year>2013</year>
<volume>131</volume>
<fpage>e964</fpage>
<lpage>e999</lpage>
<pub-id pub-id-type="doi">10.1542/peds.2012-3488</pub-id>
<pub-id pub-id-type="pmid">23439909</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Psarommatis</surname>
<given-names>IM</given-names>
</name>
<name>
<surname>Voudouris</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Douros</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Giannakopoulos</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Bairamis</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Carabinos</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Algorithmic management of pediatric acute mastoiditis</article-title>
<source/>Int J Pediatr Otorhinolaryngol
          <year>2012</year>
<volume>76</volume>
<issue>6</issue>
<fpage>791</fpage>
<lpage>796</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijporl.2012.02.042</pub-id>
<pub-id pub-id-type="pmid">22405736</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palma</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bovo</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Benatti</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Aimoni</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rosignoli</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Libanore</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Martini</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Mastoiditis in adults: a 19-year retrospective study</article-title>
<source/>Eur Arch Otorhinolaryngol
          <year>2014</year>
<volume>271</volume>
<issue>5</issue>
<fpage>925</fpage>
<lpage>931</lpage>
<pub-id pub-id-type="doi">10.1007/s00405-013-2454-8</pub-id>
<pub-id pub-id-type="pmid">23589156</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spratley</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Silveira</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Alvarez</surname>
<given-names>I</given-names>
</name>
<name>
<surname>PaisClemente</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Acute mastoiditis in children. Review of the current status</article-title>
<source/>Int J Pediatr Otolaryngol
          <year>2000</year>
<volume>56</volume>
<fpage>33</fpage>
<lpage>40</lpage>
<pub-id pub-id-type="doi">10.1016/S0165-5876(00)00406-7</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>House</surname>
<given-names>HP</given-names>
</name>
</person-group>
<article-title>Otitis media; a comparative study of the results obtained in therapy before and after the introduction of the sulfonamide compounds</article-title>
<source/>Arch Otolaryngol
          <year>1946</year>
<volume>43</volume>
<fpage>371</fpage>
<lpage>378</lpage>
<pub-id pub-id-type="doi">10.1001/archotol.1946.00680050387005</pub-id>
<pub-id pub-id-type="pmid">21028193</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goldstein</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Casselbrant</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Bluestone</surname>
<given-names>CD</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Intratemporal complications of acute otitis media in infants and children</article-title>
<source/>Otolaryngol Head Neck Surg
          <year>1998</year>
<volume>119</volume>
<issue>5</issue>
<fpage>444</fpage>
<lpage>454</lpage>
<pub-id pub-id-type="doi">10.1016/S0194-5998(98)70100-7</pub-id>
<pub-id pub-id-type="pmid">9807067</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palva</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Pulkkinen</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Mastoiditis</article-title>
<source/>J Laryngol Otol
          <year>1959</year>
<volume>73</volume>
<fpage>573</fpage>
<lpage>588</lpage>
<pub-id pub-id-type="doi">10.1017/S0022215100055742</pub-id>
<pub-id pub-id-type="pmid">14430058</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lund</surname>
<given-names>FH</given-names>
</name>
</person-group>
<article-title>Acute and latent mastoiditis</article-title>
<source/>J Laryngol Otol
          <year>1989</year>
<volume>103</volume>
<fpage>1158</fpage>
<lpage>1160</lpage>
<pub-id pub-id-type="doi">10.1017/S0022215100111260</pub-id>
<pub-id pub-id-type="pmid">2614236</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hoppe</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Koster</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Bootz</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Neithammer</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Acute mastoiditis—relevant once again</article-title>
<source/>Infection
          <year>1994</year>
<volume>22</volume>
<fpage>178</fpage>
<lpage>182</lpage>
<pub-id pub-id-type="doi">10.1007/BF01716698</pub-id>
<pub-id pub-id-type="pmid">7927813</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghaffar</surname>
<given-names>FA</given-names>
</name>
<name>
<surname>Wordemann</surname>
<given-names>M</given-names>
</name>
<name>
<surname>McCracken</surname>
<given-names>GH</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>Acute mastoiditis in children: a seventeen-year experience in Dallas</article-title>
<source/>Texas Pediatr Infect Dis J
          <year>2001</year>
<volume>20</volume>
<fpage>376</fpage>
<lpage>380</lpage>
<pub-id pub-id-type="doi">10.1097/00006454-200104000-00003</pub-id>
<pub-id pub-id-type="pmid">11332661</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dhooge</surname>
<given-names>IJ</given-names>
</name>
<name>
<surname>Alberts</surname>
<given-names>FW</given-names>
</name>
<name>
<surname>Van Cauwenberge</surname>
<given-names>PB</given-names>
</name>
</person-group>
<article-title>Intratemporal and intracranial complications of acute suppurative otitis media in children: renewed interest</article-title>
<source/>Int J Pediatr Otorhinolaryngol
          <year>1999</year>
<volume>49</volume>
<fpage>S109</fpage>
<lpage>S114</lpage>
<pub-id pub-id-type="doi">10.1016/S0165-5876(99)00144-5</pub-id>
<pub-id pub-id-type="pmid">10577787</pub-id>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Antonelli</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Dhanani</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Giannoni</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Kubilis</surname>
<given-names>PS</given-names>
</name>
</person-group>
<article-title>Impact of resistant pneumococcus on rates of acute mastoiditis</article-title>
<source/>Otolaryngol Head Neck Surg
          <year>1999</year>
<volume>121</volume>
<fpage>190</fpage>
<lpage>194</lpage>
<pub-id pub-id-type="doi">10.1016/S0194-5998(99)70170-1</pub-id>
<pub-id pub-id-type="pmid">10471856</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gliklich</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Eavey</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Iannuzzi</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Camacho</surname>
<given-names>AE</given-names>
</name>
</person-group>
<article-title>A contemporary analysis of acute mastoiditis</article-title>
<source/>Arch Otolaryngol Head Neck Surg
          <year>1996</year>
<volume>122</volume>
<fpage>135</fpage>
<lpage>139</lpage>
<pub-id pub-id-type="doi">10.1001/archotol.1996.01890140023006</pub-id>
<pub-id pub-id-type="pmid">8630206</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mathews</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Oliver</surname>
<given-names>SP</given-names>
</name>
</person-group>
<article-title>Bacteriology of mastoiditis. A five-year experience at Groote Schuur Hospital</article-title>
<source/>J Laryngol Otol
          <year>1988</year>
<volume>102</volume>
<fpage>397</fpage>
<lpage>398</lpage>
<pub-id pub-id-type="doi">10.1017/S0022215100105183</pub-id>
<pub-id pub-id-type="pmid">3397630</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meyerhoff</surname>
<given-names>WL</given-names>
</name>
<name>
<surname>Gates</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Montalbo</surname>
<given-names>PJ</given-names>
</name>
</person-group>
<article-title>Pseudomonas mastoiditis</article-title>
<source/>Laryngoscope
          <year>1977</year>
<volume>87</volume>
<fpage>483</fpage>
<lpage>492</lpage>
<pub-id pub-id-type="pmid">402522</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ostfeld</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rubinstein</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Acute gramnegative bacilliary infections of middle ear and mastoid</article-title>
<source/>Ann Otol Rhinol Laryngol
          <year>1980</year>
<volume>89</volume>
<fpage>33</fpage>
<lpage>36</lpage>
<pub-id pub-id-type="doi">10.1177/000348948008900109</pub-id>
<pub-id pub-id-type="pmid">7356263</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Halgrimson</surname>
<given-names>WR</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Abzug</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Perkins</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Carosone-Link</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Simões</surname>
<given-names>EA</given-names>
</name>
</person-group>
<article-title>Incidence of acute mastoiditis in Colorado children in the pneumococcal conjugate vaccine era</article-title>
<source/>Pediatr Infect Dis J
          <year>2014</year>
<volume>33</volume>
<issue>5</issue>
<fpage>453</fpage>
<lpage>457</lpage>
<pub-id pub-id-type="doi">10.1097/INF.0000000000000138</pub-id>
<pub-id pub-id-type="pmid">24732389</pub-id>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pang</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Barakate</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Havas</surname>
<given-names>TE</given-names>
</name>
</person-group>
<article-title>Mastoiditis in a paediatric population: a review of 11 years experience in management</article-title>
<source/>Int J Pediatr Otorhinolaryngol
          <year>2009</year>
<volume>73</volume>
<fpage>1520</fpage>
<pub-id pub-id-type="doi">10.1016/j.ijporl.2009.07.003</pub-id>
<pub-id pub-id-type="pmid">19758711</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van den Aardweg</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Rovers</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>de Ru</surname>
<given-names>JA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A systematic review of diagnostic criteria for acute mastoiditis in children</article-title>
<source/>Otol Neurotol
          <year>2008</year>
<volume>29</volume>
<fpage>751</fpage>
<pub-id pub-id-type="doi">10.1097/MAO.0b013e31817f736b</pub-id>
<pub-id pub-id-type="pmid">18617870</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bizakis</surname>
<given-names>JG</given-names>
</name>
<name>
<surname>Velegrakis</surname>
<given-names>GA</given-names>
</name>
<name>
<surname>Papadakis</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Karampekios</surname>
<given-names>SK</given-names>
</name>
<name>
<surname>Helidonis</surname>
<given-names>ES</given-names>
</name>
</person-group>
<article-title>The silent epidural abscess as a complication of acute otitis media in children</article-title>
<source/>Int J Pediatr Otorhinolaryngol
          <year>1998</year>
<volume>45</volume>
<issue>2</issue>
<fpage>163</fpage>
<lpage>166</lpage>
<pub-id pub-id-type="doi">10.1016/S0165-5876(98)00024-X</pub-id>
<pub-id pub-id-type="pmid">9849684</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rocha</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Kondo</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Gracia</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Baptista</surname>
<given-names>MI</given-names>
</name>
<name>
<surname>Büchele</surname>
<given-names>G</given-names>
</name>
<name>
<surname>da Cunha</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Martins</surname>
<given-names>LT</given-names>
</name>
</person-group>
<article-title>Central venous sinus thrombosis following mastoiditis: report of 4 cases and literature review</article-title>
<source/>Braz J Infect Dis
          <year>2000</year>
<volume>4</volume>
<issue>6</issue>
<fpage>307</fpage>
<lpage>312</lpage>
<pub-id pub-id-type="pmid">11136529</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keogh</surname>
<given-names>IJ</given-names>
</name>
<name>
<surname>Hone</surname>
<given-names>SW</given-names>
</name>
<name>
<surname>Colreavy</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gaffney</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Sigmoid sinus thrombosis: an old foe revisited</article-title>
<source/>Ir Med J
          <year>2001</year>
<volume>94</volume>
<issue>4</issue>
<fpage>117</fpage>
<lpage>118</lpage>
<pub-id pub-id-type="pmid">11440048</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>See</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Leong</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>HK</given-names>
</name>
</person-group>
<article-title>Otogenic lateral sinus thrombosis – a case report</article-title>
<source/>Ann Acad Med Singap
          <year>2000</year>
<volume>29</volume>
<issue>6</issue>
<fpage>753</fpage>
<lpage>756</lpage>
<pub-id pub-id-type="pmid">11269983</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fritsch</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Miyamoto</surname>
<given-names>RT</given-names>
</name>
<name>
<surname>Wood</surname>
<given-names>TL</given-names>
</name>
</person-group>
<article-title>Sigmoid sinus thrombosis diagnosis by contrasted MRI scanning</article-title>
<source/>Otolaryngol Head Neck Surg
          <year>1990</year>
<volume>103</volume>
<issue>3</issue>
<fpage>451</fpage>
<lpage>456</lpage>
<pub-id pub-id-type="doi">10.1177/019459989010300318</pub-id>
<pub-id pub-id-type="pmid">2122377</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ram</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Meiklejohn</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Nunez</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Watson</surname>
<given-names>HG</given-names>
</name>
</person-group>
<article-title>Combined risk factors contributing to cerebral venous thrombosis in a young woman</article-title>
<source/>J Laryngol Otol
          <year>2001</year>
<volume>115</volume>
<issue>4</issue>
<fpage>307</fpage>
<lpage>310</lpage>
<pub-id pub-id-type="doi">10.1258/0022215011907262</pub-id>
<pub-id pub-id-type="pmid">11276336</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dallari</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Zaccarelli</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Sintini</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gatti</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Balli</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Acute mastoiditis with complications: a report of two cases</article-title>
<source/>Acta Otorhinolaryngol Belg
          <year>1997</year>
<volume>51</volume>
<issue>2</issue>
<fpage>113</fpage>
<lpage>118</lpage>
<pub-id pub-id-type="pmid">9241378</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lahav</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Handzel</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Gertler</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Postauricular needle aspiration of subperiosteal abscess in acute mastoiditis</article-title>
<source/>Ann Otol Rhinol Laryngol
          <year>2005</year>
<volume>114</volume>
<fpage>323</fpage>
<pub-id pub-id-type="doi">10.1177/000348940511400412</pub-id>
<pub-id pub-id-type="pmid">15895789</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nitsche</surname>
<given-names>MP</given-names>
</name>
<name>
<surname>Carreño</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Antibiotics for acute otitis media in children</article-title>
<source/>Medwave
          <year>2015</year>
<volume>15</volume>
<issue>Suppl 2</issue>
<fpage>e6295</fpage>
<pub-id pub-id-type="doi">10.5867/medwave.2015.6295</pub-id>
<pub-id pub-id-type="pmid">26524150</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Venekamp</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Glasziou</surname>
<given-names>PP</given-names>
</name>
<name>
<surname>Del Mar</surname>
<given-names>CB</given-names>
</name>
<name>
<surname>Rovers</surname>
<given-names>MM</given-names>
</name>
</person-group>
<article-title>Antibiotics for acute otitis media in children</article-title>
<source/>Cochrane Database Syst Rev
          <year>2015</year>
<volume>6</volume>
<fpage>CD000219</fpage>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>